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 Bovine sperm sexing technology is important for both industry and livestock 
sections. Various methods have been used for bovine sperm sexing. Immunological 
method is one of the most favorable methods used, because this method does not affect 
the wanted sperm quality. This study aimed to produce monoclonal antibody (mAb) 
against bovine Y-sperm. The mAbs were produced by stimulation of female BALB/c 
mice with bovine Y-sperm injection. More than 2,000 hybridoma colonies were 
obtained after cells fusion. The cultured supernatants of the hybridoma colonies were 
used to determine the specificity against bovine Y-sperm by ELISA and sperm surface 
binding methods. Three hybridoma colonies, G16G14, G16E7 and G16E8 produced 
mAbs that were specific to bovine Y-sperm. These three hybridoma colonies were 
used to produce the mAbs to be used for sperm sexing. In the sperm sexing method, 
bovine Y-sperms were destroyed via cytotoxicity using guinea pig complement. The 
undestroyed X-sperms were used in in vitro fertilization (IVF) to determine the 
accuracy and precision of the sperm sexing method using the produced mAb. The sex 
of embryos obtained from IVF was determined by polymerase chain reaction (PCR) 
method using bovine and bovine Y-specific primers. The embryos sex determination 
indicates that the three hybridoma colonies can produce mAbs which are specific to
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CHAPTER I 
INTRODUCTION 
 
In cattle, the sex ratio is generally 50:50 (male: female). Sperm is the one to 
determine the sex of the embryo. Spermatogenesis in cattle is the process by which 
male primary germ cells undergo meiosis. The sperm cells or the male gametes in 
cattle are heterogametic that contain one of the two types of sex chromosomes. They 
are either X- or Y-chromosome. In contrast, the egg cells or the female gametes 
contain only the X-chromosome hence, they are homogametic. Each sperm has an 
equal chance of carrying the X-chromosome or the Y-chromosome (Pace, 1990). If a 
sperm cell carrying an X-chromosome fertilizes an egg, the resulting zygote will be 
female, XX. If a sperm cell containing a Y-chromosome, the resulting zygote will be 
male, XY (http://biology.about.com/od/basicgenetics/p/chromosgender.htm). 
The selection of X- or Y-bearing spermatozoa has been the goal for several 
methods developed for human and domestic animals. In livestock, various methods 
have been used to modify mammalian semen to increase the relative percentage of Y- 
or X-sperm in the semen fraction. In the dairy industry, higher number of cow for 
milk production is preferred, but higher number of bull is also preferred in beef 
industry for meat production. Here are some reasons for wanting sexed semen, 
1. Production of higher number of bulls for seed stock producers.  
2. Production of higher number of bulls for meat production. 
3. Production of replacement females from a selected population.   
4. Production of females from virgin heifers to reduce calving difficulties. 
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5. Production of higher number of cows for dairy industry. 
Sexed semen has been used to increase the efficiency of the beef and dairy 
production. It could be used to produce the offspring of the wanted sex. The benefit of 
using sexed semen is the cost reduction of progeny determination. Sexed semen could 
also be used to produce specialized, genetically superior replacement heifers from a 
small proportion of the herd (Hohenboken, 1999).  
Various methods including gel filtration, electrophoresis, swimming up, sperm 
sorting, centrifugation and immunological methods have been used in attempts to 
fractionate both human and animal sperms into X and Y enriched populations. These  
methods have been used to separate the spermatozoa into X- and Y-chromosome 
bearing fractions based on the differences of pH sensitivity (Rothschild, 1960), 
swimming speed (Ericsson et al., 1973; Rohde et al., 1973), motility (Sarkar, 1984; 
Sarkar et al., 1984), density (Haevey, 1946; Sumner and Robinson, 1976), surface 
charge (Kaneko et al., 1984; Cartwright et al., 1993), sperm surface protein (Prasad et 
al., 2010), size, head and mass (Windsor et al.,1993; Gledhill, 1988), adherence to 
Sephadex (Steeno et al., 1975; Adimoelja, 1987), H-Y antigen content ( Goldberg et 
al., 1971; Peter et al.,1993; Sills et al., 1998) and DNA content (Pinkel et al., 1982; 
Johnson et al., 1989). 
However, no method can give 100% accuracy in the semen sex selection. This 
problem might come from the large number of spermatozoa produced in each 
ejaculate and the fact that only one sperm fertilized (Pace, 1990). Semen sexing could 
also be carried out using gender specific antibodies. This method is based on the 
differences between antigens on the surface of each sperm gender. 
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Research objectives 
The purpose of this research is to produce specific monoclonal antibody 
(mAb) against bovine Y-sperms to selectively eliminate the Y-sperms. The left over 
sperms (majority X-sperms) were used to in vitro fertilize (IVF) bovine oocytes. The 
IVF embryos were checked by PCR to determine the accuracy of the sexed sperm. 
The objectives of this research are summarized as below 
1. To produce mAb against bovine Y-sperms 
-Select the monoclonal antibodies that are specific to bovine Y-sperms 
-Use the monoclonal antibodies to selectively destroy Y-sperms 
-Determine the quality of sexed sperm by fertilization efficiency 
2. To investigate the accuracy and precision of sexed sperms by determine the 
sex of embryos derived IVF using multiplex PCR 
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CHAPTER II                                                          
LITERATURE REVIEWS 
 
2.1  Antibodies  
 Antibodies (or immunoglobulin, Ig) are a group of glycoproteins molecules 
that are synthesized by the host and secreted by B-lymphocytes and plasma cells in the 
immune system. They are produced in response to the presence of foreign molecules 
to identify and neutralize invasive foreign molecules in the body.  
 
         2.1.1  Antibody structure and classification 
  The basic structures of each antibody composed of one or more copies of a 
characteristic unit that can be visualized as a Y forming shape (Figure 2.1). Each Y-
shape contains 4 polypeptides including 2 identical heavy (H) chains (~50-70 kDa) 
and 2 identical light (L) chains (~22-25 kDa) (http://pathmicro.med.sc.edu/mayer 
/igstruct2000.htm). They are linked by disulfide bonds between heavy and light chains 
in their constant regions and hydrophobic interaction in both chains.  
                   Antibodies are separated into classes based on physical characteristics 
including the structure of heavy chains, size, charge, amino acid composition, 
carbohydrate content and the number of antigen binding sites. Mammalian species 
produce 5 classes of antibodies, IgG, IgM, IgA, IgE and IgD (Harlow and Lane, 1988) 
which are distinguished by their heavy chains γ, α, µ, ε and δ, respectively 
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(Figure 2.2). They are only 2 types of light chains, kappa (κ) and lampda (λ). In mice, 
95% are κ light chains and only 5% are λ. Single antibody molecule contains only κ 
light or λ light chain. Each antibody class differs in valency as a result of different 
number of Y-shaped units that link to form the complete structure. IgG, IgE and IgD 
are of the monomeric type which containing 2H2L. IgA is mainly monomeric, but 
found as a dimer in saliva. IgM is composed of 5 monomeric units and has 10 antigen 
binding sites. The result from minor differences in the amino acid composition within 
each class, mouse IgG are divided into 4 subclasses, IgG1, IgG2a, IgG2b and IgG3 
which have g1,g2a, g2b and g3 as heavy chain (Figure 2.3). 
 
 
 
 
 
 
 
 
 
Figure 2.1  Basic Y-shaped structure of antibody consisting 2 heavy chains and 2 light 
chains. (http://www.virology.ws/2009/07/22/adaptive-immune-defenses-
antibodies/)   
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Figure 2.2  Characteristics of the immunoglobulin classes (http://www.pc.maricopa. 
edu/Biology/rcotter/BIO%20205/LessonBuilders/Chapter%2015%20LB/
Ch15LessonBuilder_print.html)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3  The overview of antibody classes and subclasses (http://www.rosenthallab 
.com/gallery/detail.php?fileName=antibody.GIF) 
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2.1.2  Function 
         The functions of each antibody class are summarized here 
(http://biochemis tryquestions.wordpress.com/2009/05/26/immunoglobulins-structure-
and-functions/): 
IgM antibodies: IgM is the primary antibody that produced first in 
immune responses. IgM is very effective in the complement activation and bacterial 
elimination. It compose of pentameric immunoglobulin (2H2L) structure (Janeway  et 
al., 2001). 
IgG antibodies: IgG is the most important immunoglobulin class which 
response for long-term protection from disease as a secondary responses. IgG is the 
dominant antibody found in blood and promotes the uptake of foreign antigens by 
immune cells.  
IgA antibodies: IgA is the secretory antibody found in mucous membrane 
secretions, tears, colostrums and milk. This is the initial defense in respiratory, 
genitourinary tracts and gastrointestinal tracts against pathogen and also found in that 
passively protects the newborn (Woof and Kerr, 2006). 
IgE antibodies: IgE is found in blood with very small concentrations. It is 
also associated with defense against parasite. IgA binds to the receptors on the 
basophiles and mast cells and plays an important role in the allergic response. 
IgD antibodies: IgD is a minor blood component that typically bound to 
the B-lymphocyte surface. 
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2.1.3  Polyclonal versus monoclonal antibodies 
                    Polyclonal antibodies (pAb) are a combination of immunoglobulins 
obtained from different lymphoid organs including spleen, lymph nodes and gut-
associated by stimulated plasma cells (B-lymphocytes). In contrast, monoclonal 
antibodies (mAbs) are the identical immunoglobulin that produced by a single B-
lymphocyte which is specific for a single antigen (epitope) (Leenaars et al., 1999).  
 
2.2  Monoclonal antibody  
 In 1975, the mAb production was discovered by Georges J.F. KÖhler and César 
Milstein. They sought the ways to create the long-living cells that could produce large 
amount of specific antibody. They fused the cancerous form of cells and normal 
antibody-producing cells together, forming the hybrid cells that could produce a 
specific antibody and also immortal. From this discovery, in 1984, they got the noble 
prizes in medicine (http://www.nobelprize.org/nobelprizes/medicine/laureates/1984 
/speedread.html).  
 
2.3   Myeloma cell 
A few mice strains can be induced to produce myeloma cells by injecting 
mineral oil into the peritoneum (Figure 2.4). In 1972, Potter isolated the myeloma 
cells from BALB/c mice and the isolated myeloma cells named mineral oil 
plasmacytoma (MOPC). The derivatives of BALB/c myeloma cells have become the 
most commonly used in the hybridoma fusion (Table 2.1) (Harlow and Lane, 1988). 
 
  
 
 
 
 
 
 
9 
 
 
Figure 2.4 Myeloma family tree (adapted from Harlow and Lane, 1988).  
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Table 2.1  Myeloma cell lines (adapted from Harlow and Lane, 1988)  
 
Cell line Reference Derived from 
Chains 
expressed Secreting Comments 
P3-X63Ag8 Köhler and Milstein (1975) P3K γ1, κ IgG1 Not recommended
X63Ag8.653 Kearney et al. (1979) P3-X63Ag8 None No Recommended 
Sp2/0-Ag14 Köhler and Milstein (1976) P3-X63Ag8 × BALB/c None No Recommended 
  Shulman et al. (1978)   
FO de St. Groth and Scheidegger (1980) Sp2/0-Ag14 None No Recommended 
NSI/1-Ag4-1 Köhler et al. (1976) P3-X63Ag8 Kappa No Recommended 
NSO/1 Galfre and Milstein (1981) NSI/1-Ag4-1 None No Recommended 
FOX-NY Taggart and Samloff (1984) NSI/1-Ag4-1 Kappa (?) No   
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2.4  Unfused myelomas drug selection 
Hypoxanthine-guanine phosphoribosyltransferase (HPRT) is an enzyme 
important for purine nucleotide synthesis via purine salvage pathway. HPRT is a 
transferase that converts hypoxanthine to inosine monophosphate and guanine to  
guanosine monophosphate by transferring the 5-phosphoribosyl group from 5-
phosphoribosyl 1-pyrophosphate to the purine.  
In the fusion step, the myeloma cells containg a mutation of HPRT that cannot 
function in the salvage pathway of purine nucleotide synthesis has been used 
(Littlefield, 1964). The nucleotide synthesis pathways of both myeloma and normal 
cells when cultured in media without any drug are shown in Figure 2.5.  
 
     B cell      HPRT- cell 
 
 
 
 
 
 
Figure 2.5  Nucleotide synthesis pathways when culture without any drug (Adapted            
from Harlow and Lane, 1988) 
From the above, the myeloma cells can survive and multiply. In contrast, B-
cells can survive with normal nucleotide synthesis pathways, but cannot multiply. To 
force the cells to use only the de novo nucleotide synthesis pathway, drug or 
× 
de Novo pathway                                                   de Novo pathway 
 
Salvage pathway              Salvage pathway 
 
      Viable                                                                          Viable 
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compounds are added into the culture media. Only the B-cells can use the salvage 
pathway. The drugs commonly use are aminopterin, methotrexate or azaserine. In the 
mAb production, the selection media used to select the fused or hybrid cells is 
hypoxanthine-aminopterin-thymidine (HAT) medium. Aminopterin, folic acid 
antagonist is a synthetic derivative of pterins.  A folate analogue works as an enzyme 
inhibitor by competing for the folate binding site of dihydofolate reductase resulted in 
the depletion of nucleotide precursors and inhibited the DNA, RNA and protein 
synthesis (Farber et al., 1948). 
The selection of fused or hybrid cells using HAT medium, only the fused cells 
between myeloma cell and B-cell will be able to grow in the media containing HAT as 
shown in Figure 2.6.  
     B cell      HPRT- cell 
 
 
 
 
 
 
 
 
 
 
Figure  2.6  Drug selection for viable hybrid cells (Adapted from Harlow and Lane, 
1988) 
×
× 
× 
× de Novo pathway                                                   de Novo pathway                                                 HAT 
Salvage pathway                  Medium                Salvage pathway 
 
      Viable                                                                      Nonviable 
de Novo pathway                         
                                                 
Salvage pathway     
 
        Viable               
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2.5   Immunizations 
Immunization is the process of person is made immune or resistant to exposed 
molecules that are foreign to the body (http://www.who.int/topics/immun ization/en). 
The ability of a molecule to induce an immune response called immunogenicity. The 
immunogenicity is determined by chemical structure of the injected molecule and the 
host recognition of that molecule (Harlow and Lane, 1988).   
 
2.6  Immunizing animals 
Immunizing and breeding animals for the production of pAb or use as donors 
for hybridoma fusions is a technically straightforward and human procedure. The 
healthy, specific pathogens free and well-cared for animals are essential for obtaining 
a good immune response. The skill, patience and practical training are required for 
animal injection to safe and reduce the pain of animal. The choice of animal in Table 
2.2 is defined by (Harlow and Lane, 1988): 
-How much serum is needed? 
-What species is the antigen isolated? 
-Are polyclonal or mAbs needed? 
-How much antigen is usable? 
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Table 2.2  Choice of animal to be used for monoclonal and polyclonal antibody production (Harlow and Lane, 1988) 
 
Animal 
Maximal amount of Sera 
(ml) 
 
mAb 
 
Inbred 
 
Comments 
 
Chickens 
 
50 
 
No 
 
No 
Good for highly conserved mammalian antigens 
Guinea 
Pigs 
30 No No Hard to bleed 
 
Hamsters 
 
20 
 
No 
 
Mostly not 
Good choice for pAb production when antigen is limiting 
 
Mice 
 
2 
 
Yes 
 
Yes 
Often best choice for mAb production, excellent genetics of 
immune response 
 
Rabbits 
 
500 
 
No 
 
No 
Often best choice for pAb production even when antigen limiting 
 
Rats 
 
20 
 
Yes 
 
Yes 
Good choice for mAb production 
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2.7  Adjuvant 
Adjuvant is an immunological agent commonly used to enhance or stimulate 
the immune responses. The action of adjuvants is not fully understood, but 
incorporated some following components (Chodaczek, 2004; Howard and Kaser, 
2006): 
 
i. Act as a reservoir of immunogen forms to protect antigens from rapid 
catabolism, resulting in the slow release and extent the period of antigen 
presentation to immune system 
ii. Act as an immune stimulating agent that is optimized by focusing a 
general immunostimulant and antigen in the microenvironment 
iii. Cells of the immune system that are nonspecifically activated, so helping 
those interactions to support the antibody production 
 
Freund’s adjuvant 
Freund’s adjuvant is an adjuvant that most commonly used for research work. 
Freund’s adjuvant is a water-in-oil emulsion prepared with nonmetabolizable oils. 
They are 2 types of Freund’s adjuvant, 
i. Complete Freund’s adjuvant (CFA): the mixture of water-in-oil emulsion 
contains killed Mycobacterium tuberculosis, a very potent immune- 
modifier.  
ii. Incomplete Freund’s adjuvant (IFA): the mixture that identical to CFA 
except that the Mycobacterium tuberculosis is omitted. 
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 It is generally assumed that IFA and CFA act by prolonging the lifetime of 
injected autoantigen, by stimulating its effective delivery to the immune system and 
by providing a complex set of signals to the innate compartment of the immune 
system, resulting in increased leukocyte proliferation and differentiation (Billiau and 
Matthys, 2001). The disadvantage of Freund’s adjuvant is that it is inherently toxic, 
resulting in granulomas, sterile abscesses and ulcerations after administration (Rizvi 
and Bashir, 2004). To avoid the side effects of Freund’s adjuvant, CFA is 
recommended to use only in the primary injection, while other boosts should be done 
with using IFA (http://www.research.uci.edu/ora/acup/freundsadjuvant.htm).  
 
2.8  Dose and form of the antigen 
The suitable dose of antigen used to induce a good immune response depends 
on the host animal and individual antigen. The suitable suggested dose for mice is 
summarized in Table 2.3. 
 
2.9  Route of injection 
The potential routes of introducing an antigen into mice are summarized in 
Table 2.4. 
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Table 2.3  Dose of immunogen for mice (Harlow E. and Lane D.1988) 
 
 
 
Primary injections and boosts 
 
Final boosts 
 
Antigen form 
 
Examples 
 
Possible routes 
 
Dose 
 
Adjuvant 
Possible routes  
Dose 
 
Adjuvant 
 
Soluble proteins 
Enzyme 
Carrier proteins conjugated    
      with peptide 
Immune complex 
ipa 
scb 
 
5-50 µg 
 
+ 
 
ivc 
 
5-50 µg 
 
- 
 
Particulate proteins 
Viruses (killed) 
Yeasts (killed) 
Bacteria (killed) 
Structural proteins 
ip 
sc 
 
5-50 µg 
 
+ 
 
iv 
 
5-50 µg 
 
- 
 
Insoluble proteins 
Bacterially produced from   
     inclusion bodies 
Immunopurified proteins  
      bound to beads 
ip 
sc 
 
5-50 µg 
 
+ 
 
ip 
 
5-50 µg 
 
- 
 
Live cells 
Mammalian cells ip  
105-107 cells 
 
- 
 
iv 
 
106 cells 
 
- 
 
Live Tumorigenic cells 
Oncogenic mammalian cells ip 
sc 
 
104-106 cells 
 
- 
 
iv 
 
106 cells 
 
- 
 
Carbohydrates 
Polysaccharides 
Glycoproteins 
ip 
sc 
 
10-50 µg 
 
+/- 
 
iv 
 
10-50 µg 
 
- 
 
Nucleic acids 
Carrier proteins conjugated with N.A. ip  
10-50 µg 
 
+ 
 
iv 
 
10-50 µg 
 
- 
a, Intraperitoneal; b, Subcutaneous;  c, Intravenous 
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Table 2.4 Route of mice injection (Harlow and Lane, 1988) 
 
 
Route 
 
Abbreviation 
Uses  
Maximum 
volume (ml) 
 
Adjuvant 
 
Immunogen requirement 
 
Comments Primary 
injection and 
boosts
 
Final boost 
 
Intraperitoneal 
 
ip 
 
Good 
 
Fair 
 
0.5 
 
+/- 
 
Soluble/or insoluble 
If used for final boost, 
wait 5 days before 
fusion 
 
Subcutaneous 
 
Sc 
 
Good 
 
Poor 
 
0.2 
 
+/- 
 
Soluble/or insoluble 
Local response, 
Serum level slower    
   to increse 
 
 
Intravenous 
 
 
iv 
 
 
Poor 
 
 
Good 
 
 
0.2 
 
 
No Frend’s 
Soluble,  
Ionic detergent <0.2% 
Nonionic detergent <0.5% 
Salt <0.3M 
Urea <1M 
 
 
Poor immunizing 
 
Intramuscular 
 
im 
 
Not recommended for mice 
    
 
Intradermal 
 
id 
 
Not recommended for mice 
    
 
Lymph node 
  
Special uses 
 
0.1 
 
No Frend’s 
 
Soluble/or insoluble 
Good applications  
   for experienced  
   workers 
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2.10  Sperm sexing technology 
Sperm sexing technology is a goal in both agricultural industry and livestock 
sections. This technology used to control the sex of offspring of agriculturally 
important animals by altering the sex ratio. In livestock, the sex can be altered ratio to 
increase the milk production for dairy industry and also increase the meat for meat 
industry. Various methods have been used for sperm sexing including gel filtration, 
electrophoresis, swimming up, sperm sorting, centrifugation and immunological 
methods. These methods have been used to separate the spermatozoa into X- and Y-
chromosome bearing fractions based on: 
 
I.  The differences of pH sensitivity  
In 1960, Rothschild proposed that male sperms preferred an alkaline 
environment and female sperms preferred a more acid environment. Hassan in 2005 
also confirmed that the sperm separation efficiency of an alkaline pH 9.0 resulted in 
the high amount of Y-sperms (60.28%). In contrast, Diasio and Glass in 1971 studied 
the effect of pH on the migration of X- and Y-sperm. The results indicated that the X- 
and Y-sperms cannot be distinguished on the basis of the migration through media of 
varying pH.  
II.  Motility and swimming speed  
                  Sperm separation using the motility and swimming speed is based on the 
active sperm migration. In 1973, Rhode et al. reported that a small number of Y-
sperm from the frontal zone during active migration when using an in vitro method for 
horizontal sperm penetration. In the same time, Ericsson et al. (1973) reported that 
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they could enrich Y-sperm by allowing the sperm to swim into a solution containing 
high concentration of bovine serum albumin. Sarka et al., (1984) also reported the 
success of enriching X- and Y-sperm to 80% purity using a laminar-flow fractionation 
method. 
Check and Katsoff (1993) found that 88.5% yielded male birth using 
modified swim-up method for sperm separation and 83.6% of Y-sperms were obtained 
from stained sperm with quinacrine using the same separation. In contrast, Han et al., 
(1993); De Jonge et al., (1997) and De Jonge, (1999) found that this method did not 
significant change in the ratio of X- and Y-sperm, but increased only 1-2% Y-sperm. 
In addition, Penfold et al., (1998) found that Y-sperm did not swim faster than X-
sperm when using simple salt. 
 
III.  Density  
X-sperm contains DNA content higher than Y-sperm (Simpson and 
Larson, 2002) which make the Y-sperm lighter and better swimming ability than the 
X-sperm. From the differences of DNA content, the sperms can be separated on their 
sedimentation velocity. Cui and Matthews (1993) observed the average size of X-
sperm and found that X-sperms are bigger and longer than Y-sperms. They 
recommended that if the X-sperms head size effects the separation using Percoll 
gradient, then the X-sperms might sediment faster than the Y-sperms. They found the  
slight increase of X-sperm when using 95% Percoll (Samura et al., 1997). 
Bongso et al. (1993) reported that the most effective sperm separation 
method used for frozen sperm is a single Percoll layer. De Maistre et al. (1996) also 
reported that the sperm membrane characteristics were enhanced when separated with 
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Percoll.  But Sharma et al. (1997) contradicted that report because they found that the 
double column was more efficient in separating than single. No difference of the 
amount of motile sperm was found when using Percoll separation was used by 
Mushayandebvu et al., 1995 and Smith et al., 1995. Abnormal sperm samples were 
separated using Percoll and mini-Percoll columns, the result indicated that the greater 
motile sperm yields were obtained (Ng et al. 1992). 
The multiple discontinuous Percoll density gradient centrifugation 
method has been used for the sperm selection and found that over 77% from many 
reports were obtained. Watkins et al. (1996) reported that the X-sperms obtained from 
this method have greater longevity in motility and have shorter tails. Andersen and 
Byskov (1997) found that when seven-step Percoll gradient (100%-40%) underlayered 
with 100% NycoPrep was used for sperm separation, resulted in the greatly 
enrichment of X- and Y-sperm.  
Mohri et al. (1986) reported that the X-sperms sediment faster than the 
Y-sperms when separated using 12 steps discontinuous Percoll density gradient and 
94% purity of X-sperms were obtained. Kobayashi et al. (2004) found that the female 
sex ratio was slightly increased to 52.9% when sperms were separated using 
discontinuous Percoll gradients method.  
However, the sexed-sperms obtained from sperm separation using 
Percoll gradient were affected from the toxicity of Percoll (Chen and Bongso, 1999). 
Resende et al. (2011) reported the percent increased of female embryos derived IVF 
using sexed-sperm obtained from Percoll gradient. They found the female sex ratio 
increased to 62% and considered that sperm selection using Percoll was possible to 
use for sperm sexing. 
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Rohde et al. (1975) reported that the Y-sperms can be separated by 
centrifuged at 26,400 ×g in a discontinuous sucrose gradient. Corson et al. (1984) and 
Dmowski et al. (1979) also successfully enriched Y-sperms using albumin gradient 
centrifugation. However, Evan et al. (1975) and Ross et al. (1975) could not enrich Y-
sperm using the same method. Beernink and Ericsson (1982) also observed that 79% 
male birth ratio from 84 delivered and after that Ericsson and Beernink (1987) 
reported again that they found 73% male from 454 birth when sperms were separated 
by albumin gradient. Jaffe et al. (1991) confirmed the results of sexed-sperm got from 
albumin gradient sperm separation increased the Y-sperm ratio after used for IVF. 
Lobel et al. (1993) reported that Y-sperms separation using albumin separation 
method altered the sex ratio of clinically relevant. However, Zavos (1985) suggested 
that sedimentation methods using albumin gradients may not be effective for 
separating X and Y-spermatozoa. Chen et al. (1997) also found that Y-sperm 
separation using albumin did not alter and did not increase the Y-sperm ratio. 
 
IV.  Surface charge  
The different in DNA content between X- and Y-sperm, might affect the 
surface proteins of the sperms. Nevo et al. (1961) and Bangham (1961) agreed that 
non motile sperms have negative charge on the outter surface and move to anode.  It 
has been proposed that the electrical charges of each X- and Y-sperm were different. 
It might be related to the nearaminic acid containing glycoproteins on the X-sperms 
membrane surface (Prasad et al., 2010). The method used for sperms separation based 
on the differ of surface charge is the free flow electrophoresis, that used tromethamine 
(THAM) buffer to separate the sperm into 2 populations. Schroder (1941) reported 
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that the electrophoresed-sperms used in insemination changed the sex ratio from 
normally expected. In 1957, Gordon also found the similar results.  
Ishijima et al. (1991) reported that the sperms can be separated by 2 
different methods, using a laser-rotating prism and using an electrophoretic light 
scattering spectrophotometer. The results found that more than 95% X-sperm and 80% 
Y-sperm were obtained from using zeta potential at -20 and -15 mV, respectively. 
Blottner et al. (1994) found that X-sperms were enriched in the cathode and Y-sperms 
were enriched in anode. Manger et al. (1997) confirmed that the results from sperm 
separation using this method were similar to Blottner (1994). However, some research 
groups found little or no proof to confirm the separation using electrophoresis to 
increase the sex ratio (Siljander, 1936; Kordts, 1952; Pilz, 1952 and Vesselinovich, 
1960) and the motility of the electrophoresed sperms is normally lost (Gledhill, 1988). 
 
 V.  Sperm surface protein   
Histocompatibility Y-chromosome antigen (H-Y) is a male specific 
antigen found in many male mammalian tissues. H-Y antigen is postmeiotic expressed 
(Koo et al. 1979) and expressed in testis (Müller et al, 1978), spleenocytes (Brunner et 
al. 1987) and white blood cells (Brunner et al. 1987). From its expression location, H-
Y positive sperms could be separated using the antibody against H-Y antigen.  
H-Y antigen has been used in sexing method including sperm and embryo 
sexing by producing antibodies against H-Y antigen (Epstein, 1980; Wachtel, 1988; 
Avery and Schnidt, 1989; Patthanawong et al., 2010).  Bennett and Boyse (1973) 
reported that when sperms were treated with anti H-Y followed by adding the 
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complement, the X-sperms were higher than Y-sperms 8%. Koo et al. (1973) also 
confirmed that sperms were separated into 2 groups using the H-Y antigen and 
considered that H-Y antigen was higher expressed in Y-sperm (Koo et al. (1979). 
Zavos (1983) and Ali et al. (1990) treated sperms using the anti H-Y antigen. 
However, they found that H-Y antigen is absorbed on the cell membrane of both X- 
and Y-sperms during spermatogenesis (Burgoyne et al., 1986; Burgoyne, 1987; 
Hassan, 2005; Prasad et al., 2010).   
 Hendriksen et al. (1993) studied about the binding of anti H-Y antigen to 
separated X- and Y-chromosome bearing porcine and bovine sperm. The results found 
that their experiments did not demonstrate the H-Y antigen is favored expressed in Y-
sperms and found similar in anti H-Y antigen binding between X- and Y-sperms.  
Howes et al. (1997) found that no difference between X- and Y-sperm surface 
membrane when run on SDS-PAGE, but found the X-specific protein when compare 
using two-dimensional SDS-PAGE. Scott Sills et al. (1998) found the H-Y antigen 
was higher slightly expressed in human Y-sperms, but it also found the expression in 
X-sperms. Form their results suggested that H-Y antigen might not be appropriate for 
human sperms sex selection.  
 
VI.  Size and shape 
Size and shape are the criteria that often used for sperm separation. X-
sperms have been supposed to be bigger than Y-sperms. Shettles (1961) claimed that 
the sperms can be separated into 2 groups using the different of sperm morphology. In 
1972, Roberts present the idea about the different in the size between X- and Y 
sperms. Mc Evoy (1992) reported that about 3-4% DNA difference in X- and Y-sperm 
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DNA, but their idea did not have evidences to support and could not be repeated. Cui 
(1997) found the length, perimeter, sperm head area, the length of sperm neck and 
tails of X-sperms were significantly larger and longer than Y-sperms. Based on their 
experimented in 2001, Hossain et al. found that size and shape of X- and Y-sperms 
were similar. 
  
VII.  Adherence to Sephadex  
Steeno and Adimoelja (1975) reported human sperm separation using 
filtration though Sephadex gel. Sexed-sperms that bound to Sephadex showed higher 
percent of Y-sperms (Pearson and Bobrow, 1970). In 1984, Adimoelja reported that 
sperms that passed though the Sephadex gel filtration are enriched for the X-sperms. 
Quinlivan et al. (1982) have confirmed the results of sperm sex selection using 
Sephadex method by counting F-body on sperms. Vidal et al. (1993) reported that the 
result of filtrated sperm obtained from Sephadex was slightly increased the Y-sperm 
to 52.5%. However, other researchers have not been able to repeat this finding 
(Downing et al., 1976; Schilling et al., 1978). Beckett et al. (1989) also found that the 
Sephadex treated sperms did not significantly increase the sex ratio of X- and Y-
sperms. 
 
VIII.  DNA content  
Sperm sexing based on DNA content is the most successful method that 
often used to separate sperms. Flow cytometric cell sorting technique was used to 
measure the difference of DNA content between X- and Y-sperm (Garner and Seidel, 
2008). The difference of DNA content in mammalian X-sperm contain from ranges       
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2.8-7.5% more DNA than Y-sperm (rabbit 3.0%, pig 3.6%, horse 3.7%, sheep 4.2%, 
cow and bull 3.8-4.2%) (Renaville et al., 2002; Prasad et al., 2010). Sperms treated 
with fluorescence dye and the differences of the fluorescence dye can be used to 
separate the sperms (http://www.gpo.or.th/rdi/html/Flow-cytometry.html; Garner et al. 
1983; Van Dilla et al., 1985).  Johnson et al., (1987) and Johnson (1992) separated 
bull, boars, rams and chinchilla sperm using flow sorting method.  
Johnson and Welch (1999) reported the production rated of X- or Y-
sperm fraction was obtained at 6 ×106 sexed sperm with 90% or more of one sex 
sperm and now have been applied in rabbits, swine, cattle or horse (Johnson et al., 
1989; Rath et al., 1999; Cran et al., 1995). 
The sex ratios of sexed-sperm obtained from flow cytometry increased 
from 50:50 to 85 to 98% of one sex. The fertility rate of flowed sexed-sperm is about 
12 to 25% which is lower than unsexed-sperm but have displayed completely normal 
morphological appearance and reductive function (Johnson, 1997).Johnson (2000) 
produced highly enriched X- or Y-sperms using flow cytometry. However, this 
method is limited by the use of machine, the cost, the low sorting rate, mutagenic 
effects, very low survived sperm, low fertility,  (Hudson et al., 2012; Garner and 
Seidel, 2008; Prasad et al., 2010 ). 
 
2.11  Bovine embryo development 
Normal fertilized embryos started mitotic cell division from 1-cell into a 
multicellular embryo (Figure 2.7). Two-cell embryos stage normally found at day 2 
and the embryos continue to multiply and develop to blastocyst and hatched blastocyst 
at day 7-9 (Wong et al., 2010; Leidenfrost et al., 2011). The normal bovine embryo  
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development time is shown in Table 2.5. 
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Table 2.5 The general bovine embryo development. (Adapted from: http://www.geochembio.com/biology/organisms/cattle/cattle-
life-cycle.html) 
 Fertilized 
egg 
(day) 
2 cell 
 
(day) 
4 cell 
 
(day) 
8 cell 
 
(day) 
16 cell 
 
(day) 
Morula 
 
(day) 
Early 
Blastocyst 
(day) 
Blastocyst 
 
(day) 
Expanded 
Blastocyst 
(day) 
Hatched 
Blastocyst 
(day) 
Expanding 
Hatched 
Blastocyst 
(day) 
Day* 0 1 2 3 4 4-5 6 6-7 6.5-7.5 7-8 8-9 
*Day after fertilization 
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Figure 2.7  Embryo developments in each stage (http://www.fao.org/DOCREP/004/ 
T0120E/T0120E07.htm) 
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CHAPTER III                                                        
MATERIALS AND METHODS 
 
3.1  Monoclonal antibody production 
3.1.1  Preparation of antigens for immunization 
      Frozen bovine Y-sperms purchased from China Mengniu Dairy Company 
Limited, China, were thawed in 37oC water bath for 30 sec and then 100 µl of Y-
sperms were transferred into 2 ml of pre-incubated Tyrode albumin lactate pyruvate 
medium (TALP). The TALP was pre-incubated at 38.5°C under humidified 
atmosphere of 5% CO2 in air for 6 hrs prior to use. The 2 ml TALP containing bovine 
Y-sperms were incubated at 38.5°C, under humidified atmosphere of 5% CO2 in air 
for 45 min. After that, approximately 1,800 ul of the upper layer of supernatant 
containing motile spermatozoa from each tube were pooled and centrifuged at 540 ×g 
for 7 min. The pellet was resuspended in 4 ml phosphate buffer saline (PBS), pH 7.2 
and centrifuged 2 times. The bovine Y-sperms were then adjusted to 2.5 × 105 
sperms/ml for the first injection and the first boost and 2.5 × 106 sperms/ml for the 
final boost. 
3.1.2  In vivo immunization          
         Two 8-weeks old female BALB/c mice purchased from the National 
Laboratory Animal Center, Mahidol University, were first intraperitoneally (ip) 
injected with 200 µl mixture of 1:1 bovine Y-sperm and Complete Freund’s Adjuvant 
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(Sigma®). The mice were boosted intravenously (iv) and subcutaneously (sc) 2 times 
at week 2 and 4 with 200 µl mixture of 1:1 bovine Y-sperm and Incomplete Freund’s 
Adjuvant (Sigma®). 
 3.1.3  Myeloma cell  
      X63-Ag8.635 myeloma cell line obtained from Department of 
Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University was used in 
the fusion step. Two weeks before the fusion, the cells were rapidly thawed in 37oC 
water bath until completely melted. Then the thawed myelomas were transferred into 5 
ml pre-warmed serum free Roswell Park Memorial Institute-1640 (RPMI) medium 
and centrifuged at 4oC, 300 ×g for 5 min. The supernatant was discarded and the cell 
pellet was transferred into a 75 ml culture flasks containing 20 ml pre-warmed 
Roswell Park Memorial Institute-1640 containing 20% fetal bovine serum (FBS) 
(cRPMI). The flasks were then incubated at 37oC under humidified atmosphere of 5% 
CO2 in air. The cultured media was changed at day 7 and cultured another 7 days until 
used. 
3.1.4  Feeder cells preparation 
                  A 10-weeks old female BALB/c mouse was euthanized by cervical 
dislocation and the skin was striped from the abdominal wall. Ten ml of cRPMI were 
injected into the peritoneal cavity. The peritoneal fluid was withdrawn using syringe 
and kept at 4oC until used. The peritoneal fluid from 1 mouse was brought up to 100 
ml by cRPMI. 
 3.1.5  Spleen cell collection                                                                           
          Two immunized mice (3.1.2) were euthanized by cervical dislocation. The  
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abdominal area was sprayed with 70% ethanol, and the spleens were removed by 
sterile operation. After that, both spleens were placed in a sterilized Petri dish 
containing 70% ethanol for 30 sec and then transferred to sterile Petri dish containing 
PBS and 3x penicillin-streptomycin (300 unit/L penicillin and 300 µg/L streptomycin) 
for 5 min to reduce the chance of bacterial contamination. During the soaking, the 
spleens were trimmed and any contaminating tissues were removed. Then the spleen 
cells were transferred into sterile Petri dish containing RPMI.  
3.1.6  Cell fusion 
                   The spleens were clipped off and minced using 19-gauge needles. The tear 
was continued until most of the spleen cells have been released. Any cell clumps were 
disrupted by pipetting. The spleen cells were transferred into a sterile centrifuge tube. 
The 2 weeks myeloma cells cultured were transferred to another sterile centrifuge tube 
using pipette. Both spleen cells and myeloma cells were washed with 40 ml 
prewarmed RPMI 3 times and spin at 300 ×g for 5 min. The cells number of each cell 
type were counted using hemacytometer chamber. The cells were mixed together at 
the ratio of 1:6.4 (myeloma cells : spleen cells) in a new sterile centrifuge tube 
containing prewarmed RPMI and then centrifuged at 37 oC, 300 ×g for 5 min. The 
supernatant was discarded and the pellet was left to dry. Prewarmed 1.5 ml 
polyethylene glycol-4000 (PEG-4000) were gently added and waited 30 sec before 
slowly added drop wise into 10 ml pre-warmed RPMI over the first 5 min followed by 
filling up to 50 ml. The cells were collected by centrifugation at 37oC, 300 ×g for 5 
min. The supernatant was discarded and the cells were resuspended in pre-warmed 
hypoxanthine-aminopterin-thymidine (HAT) medium and the cells were adjusted to a 
concentration of 2-4.5 x 105 spleen cells/ml. The resuspended cells were plated into 24 
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well culture plates at 1 ml/well and incubated at 37oC under humidified atmosphere of 
5% CO2 in air.  
 At day 4 and 5, the wells were observed under inverted microscope to check 
for contamination. The contaminated wells were eliminated by adding 200 µl of 20% 
CuSO4 solution. After 7-10 days, 0.5 ml of the supernatant from each well was 
discarded and replaced with 0.5 ml HT medium containing feeder cells. Every 3 days, 
half of the culture medium was replaced.  
 
3.2  Screening assay 
When the hybridoma cells were grown to about 2-3 mm, the supernatant was 
used to screen for antibody specificity against bovine sperms and egg yolk (negative 
control) using ELISA method. 
ELISA 
Frozen unsexed bovine sperms were thawed and swamp up as described in 3.1.1. 
The sperm concentration was adjusted to 2 x 105 sperms/ml. Fifty µl of the sperms 
suspension were added into each well of 96 well ELISA plates. Fifty µl of 0.5% egg 
yolk in PBS was used as negative control. The plates were incubated at 37oC 
overnight. The bovine sperm cells were fixed with absolute ethanol for 5 min and 
washed 3 times with PBS before blocked with 100 µl of 5% skim milk overnight at 
4oC. The blocking solution was discarded and the wells were washed 3 times with 
PBS. Fifty µl of hybridoma cells cultured media used as antibody were added into 
each wells and incubated at 37oC for 1 hr. The well were washed 3 times with PBS + 
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0.05% Tween 20 (PBST) and then 50 µl of 1:2,000 alkaline phosphatase-conjugated 
goat-anti-mouse IgG were added into the wells and incubated at 37oC in for 1 hr. The 
alkaline phosphatase-conjugated goat-anti-rabbit IgG was discarded followed by 
washing 3 times with PBST. Fifty µl of p-Nitrophenyl phosphate (pNPP) substrate 
were added to each wells and incubated at room temperature in the dark for 1 hr. 
Optical density (OD) at 405 nm of each well was measured and recorded. 
 
3.3  Hybridoma cloning (modified limiting dilution method) 
         The hybridoma cells in the positive wells were diluted by resuspend 5 µl of 
hybridoma cells into 10 ml cRPMI containing feeder cells. Seven ml of the hybridoma 
cells suspension were added into the 96 culture plate by dropping 3 drops/well using 
10 ml Sero pipette into row A and B, then 2 drops/well into row C and one drop/well 
into row D. After that 4 ml of cRPMI containing feeder cells were added into the 
remaining 3 ml of the hybridoma cells suspension. The hybridoma cells suspension 
were mixed  and then dropped 3 drops/well into the row E and F, then 2 drops/well 
into row G and one drop/well into row H. The plates were then incubated at 37oC 
under humidified atmosphere of 5% CO2 in air. At day 5, the single colony was 
observed and the supernatant was collected for rescreening using ELISA method as 
described in section 1.3.1.6. 
 
3.4  Monoclonal antibody binding on the bovine Y-sperm surface 
 To confirm that the selected mAbs were specific to only bovine Y-sperm 
surface, the bovine Y-sperms were used as positive control while X-sperms were used 
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as negative control in the binding assays. The sperms were separately smeared on 
clean glass slides and incubated at 37oC overnight. The coated sperms were fixed with 
absolute ethanol for 5 min at room temperature and washed 3 times with PBS. The 
coated sperms were blocked with 5% skim milk for 3 hrs at room temperature. The 
glass slides were washed 3 times with PBS and 50 µl of cultured supernatant were 
dropped onto the glass slide. The glass slides were incubated at 37oC for 1 hr and 
washed 3 times with PBST. One hundred µl of 1:5,000 goat anti-mouse IgG 
conjugated with fluorescein isothiocyanate (FITC) were dropped onto the glass slide 
and incubated for 1 hr. The glass slides were washed 3 times with PBST before the 
binding was observed under fluorescence stereo microscope. 
 
3.5  Hybridoma cells cryopreservation and thawing 
 The hybridoma cells were harvested by centrifugation at 300 ×g for 5 min. The 
supernatants were collected and kept at 4oC until used. The cell pellet was mixed with 
1 ml of pre-cooled -20oC 10% DMSO (Dimethyl sulfoxide) in cRPMI. The hybridoma 
cells suspension were rapidly transferred into cryopreservation tubes. After the caps 
were rapidly closed, the tubes were stored at -80oC overnight and then transferred to 
aluminum canes in liquid N2. 
 The frozen hybridoma cells were thawed by removed the cryopreservation tube 
from liquid nitrogen (LN2) and rapidly thawed in 37oC water bath. While tiny pieces of 
ice still remained in the cell suspension, the cell suspension were diluted with cold 10 
ml RPMI drop wise with gentle mixing to reduce the DMSO concentration. The 
hybridoma cells were harvested by centrifuged at 300 ×g for 5 min at 4oC. The 
supernatant was discarded. The cell pellet was resuspended in prewarmed 10 ml 
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cRPMI and transferred to 25 ml culture flasks and cultured at 37oC under humidified 
atmosphere of 5% CO2 in air. 
 
3.6  Monoclonal antibody purification 
 The selected mAb was purified using ammonium sulfate precipitation method. 
Saturated ammonium sulfate was prepared by adding 761 g of ammonium sulfate to    
1 L distilled water. While the mAb is being stirred gently at 4oC, equal volume of 
saturated ammonium sulfate was slowly added to bring the final concentration to 50% 
and continue stirring overnight. The precipitant was harvested by centrifuged at 
20,000 ×g for 30 min at 4oC. The supernatant was carefully discarded and the 
precipitant was washed with 50% saturated ammonium sulfate then harvested again. 
The pellet was resuspended using PBS with the least volume possible. The mAb 
solution was transferred to dialysis tubing and dialyzed against PBS. The PBS was 
replaced 3 times before the remaining debris was removed by centrifugation at 20,000 
×g for 15 min at 4oC. The purified mAb was aliquoted to 1.5 sterile tubes and kept at    
-20 oC until used. 
 
3.7   Monoclonal antibody characterization 
3.7.1  Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
                    SDS-PAGE of 12% was used to determine the molecular weight of 
produced mAb compare to standard protein marker (B) according to the Amersham 
Bioscience’s protocol. All reagent used were prepared as shown in the Appendix I. 
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Polyacrylamide gels were prepared according to standard protocol. Samples were 
mixed with loading dye and boiled for 5 min before loaded into well. The gels were 
run at 30 mA in 1x running buffer for 90 min. After that one gel was stained with 
coomassie for 15 min and then destained with destain solution.  
 
3.7.2  Western blotting 
    A gel obtained from SDS-PAGE, nitrocellulose membrane and filter 
papers were soaked in transfer buffer for 5 min before set up. The transfer sandwich 
was set up by the wet filter papers were firstly placed on the semi-dry transfer 
chamber and followed by nitrocellulose membrane, gel and filter papers as shown in 
Figure 3.1.  The machine was run at constant 400 mA for 2 hrs. The blotted membrane 
was blocked by soaking in 5% skim milk in PBS overnight with shaking. The blocking 
solution was discarded and the membrane was washed 3 times with PBS for 15 min. 
Diluted of goat anti-mouse Ig (H+L), human adsorbed conjugated with alkaline 
phosphatase in 10 ml PBS were added into the box. The membrane was incubated at 
room temperature with shaking for 2 hrs then discarded. The membrane was washed 3 
times with PBST for 15 min and 5 ml of 1x of 5-Bromo-4-chloro-3-indolyl 
phosphate/Nitro blue tetrazolium (BCIP/NBT) was added. The color was developed 
by incubated the membrane in the dark at room temperature for 1 hr. The reaction of 
alkaline phosphatase was stopped by washing the membrane with water. 
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Figure 3.1  The electrophoratic blotting system using semi-dry transfer chamber.   
                  (http://www.cardio-research.com/protocols/western-blot) 
 
3.7.3  Monoclonal antibody isotype and subtype identification 
                  The antigen-dependent procedure for isotype determination was used to 
determine the heavy chain classes and light chain types of the mAbs using 
ImmunoPure® MAB Isotyping Kit II (PIERCE, Rockford, IL). The procedure was 
performed followed the manufacturer’s recommendations with slight modification. 
Briefly, 50 µl of the bovine Y-sperm were coated into each of the nine wells and 
incubated at 37oC for 2 hrs. The sperms were fixed with absolute ethanol for 5 min 
and washed 3 times with PBS before blocked with 100 µl of 5% skim milk overnight 
at 4oC. The blocking solutions were discarded and the wells were washed 3 times with 
PBS. Twenty µl of purified mAbs were added into each wells and incubated at 37 oC 
for 1 hr. The wells were washed 3 times with PBST and then 50 µl of normal rabbit 
serum (negative control) or subclass-specific anti-mouse immunoglobulins were added  
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to each bovine Y-sperm coated well. The plate was incubated at 37oC for 1 hr and 
washed 3 times with PBST. Fifty µl of 1:2,000 alkaline phosphatase-conjugated goat-
anti-rabbit IgG were added into each wells and incubated at 37oC for 1 hr. The alkaline 
phosphatase-conjugated goat-anti-rabbit IgG were discarded. The plates were washed 
3 times with PBST. Fifty µl of pNPP substrate were added in each wells and incubated 
at room temperature under dark condition for 1 hr. The Optical density of each well 
was measured at 405 nm. 
 
3.8 The effects of guinea pig complement concentrations and     
incubation time on sperm survival 
            Frozen bovine-sperms were thawed in 37oC water bath for 30 sec and 100 µl of 
the thawed sperm were transferred into the 2 ml pre-incubated at 38.5°C TALP prior 
to use. The guinea pig complement was added into each pre-incubated TALP tube to 
the final concentration of 2, 5 and 10% and then the TALP tubes were incubated at 
38.5oC under humidified atmosphere of 5% CO2 in air with varied incubation time of 
15 and 30 min. After the incubation, approximately 1,800 µl of the upper layer of 
supernatant containing the motile sperm were centrifuged at 540 ×g for 7 min. The 
sperm pellet was resuspended and the survived sperms were observed and counted 
under inverted microscope. The final concentration of guinea pig complement with the 
highest amount of survived sperms was selected. The effect of guinea pig complement 
incubation time was done as mentioned above excepted only the incubation times were 
varied to 15, 30 and 45 min. The appropriated final concentrations of guinea pig 
complement and incubation time were selected for sperm sexing.
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3.9  Sperm sexing 
 Forty µl of each selected mAbs were mixed with 2 ml pre-incubated TALP and 
incubated at 38.5oC under humidified atmosphere of 5% CO2 in air.  Frozen bovine 
sperms were thawed in 37oC water bath for 30 sec and 100 µl of the thawed sperm 
were transferred into the 2 ml pre-incubated TALP containing mAb and then the tubes 
were incubated at 38.5oC under humidified atmosphere of 5% CO2 in air for 20 min. 
The final concentration of guinea pig complement concentration at 2% was mixed into 
the TALP-sperms containing tube by gently mixing using fine-tip pipette and then 
incubated at 38.5oC under humidified atmosphere of 5% CO2 in air. After 45 min of 
incubation, approximately 1,800 µl of the upper layer of supernatant containing the 
motile sperm were pooled and centrifuged at 540 ×g for 7 min. The pellet was 
resuspended in 4 ml pre-incubated TALP and the sexed sperms were harvested by 
centrifugation at 540 ×g for 7 min again. The sexed-sperms concentration was 
adjusted to 4 × 106 sperms/ml for in vitro fertilization (IVF).  
 
3.10  In vitro fertilization and embryos collection 
  3.10.1  Oocyte collection and preparation 
Bovine ovaries were collected from local abattoir and kept in 0.9% 
NaCl during transported to the laboratory at F1, Suranaree University of Technology. 
Cumulus-oocyte complexes (COCs) were collected from the follicles of 2-8 mm in 
diameter using 18-gauge needle attached to a 10 ml syringes (Figure 3.2B). The 
collected COCs  (Figure 3.2C) were washed 5 times with modified Dulbecco’s 
phosphate buffered saline (mDPBS) supplemented with 0.1% polyvinyl pyrolidone 
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(PVP) and 3 times in in vitro maturation (IVM) medium. Twenty to twenty five COCs 
were then cultured in 100 μl droplets of IVM medium covered with mineral oil under 
humidified atmosphere of 5% CO2 in air at 38.5°C for 23 hr. 
 
                                                                                                                                
 
 
 
A 
 
 
 
Figure 3.2 Oocyte preparation. Bovine ovaries (A) were collected from local 
abattoir. COCs were collected from the follicles of 2-8 mm in diameter 
using 18-gauge needle attached to a 10 ml syringes (B). COCs after 
aspirated from ovaries (C).  
 
A B
C
  
 
 
 
 
 
 
42 
 
3.10.2  In vitro fertilization and embryo culture 
After IVM, the cumulus cells were mechanically removed by repeat 
pipetting in 0.2% hyaluronidase using a fine-tip pipette and were washed 5 times 
in SYNGRO® Holding medium (BIONICHE ANIMAL HEALTH USA, INC.). The 
concentration of sexed-sperm was adjusted to 4 × 106 sperms/ml with TALP. Ten to 
twenty oocytes were grouped and washed 3 times in TALP then placed in fertilization 
droplets and cultured with the sexed-sperms for 10 hr at 38.5°C under humidified  
atmosphere of 5% CO2 in air. The sperms that collected at the same time and same 
breeder were used as control group. The preparation of sexed-sperms was repeated 4 
times for each mAb and the IVF was done with 50 oocytes/treatment. After 
fertilization, the embryos were subsequently washed and cultured in the mSOF 
medium supplemented with 3 mg/ml BSA (Laowtammathron et al., 2005) and 
covered with mineral oil. Twenty presumptive zygotes were grouped and placed in 
each culture drop and then cultured at 38.5°C under humidified atmosphere of 5% O2, 
5% CO2 and 90% N2 for 2 days. The day of IVF was counted as Day 0. After 2 days, 
8-cell-stage embryos were selected and co-cultured with bovine oviduct cells in 
mSOF medium at 38.5oC under an atmosphere of 5% CO2 in air for an additional 6 
days. The culture medium was changed daily.  
 
3.11  Multiplex polymerase chain reaction (PCR) optimization for 
embryo sex determination 
Genomic DNAs used as positive control in multiplex PCR reaction were 
extracted from male and female bovine fibroblast using Ultraclean® tissue & cells 
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DNA isolation Kit (Catalog No. 12334-50, Mo-Bio Laboratories, inc.) followed the 
manufacturer’s protocol. Briefly, male and female bovine fibroblasts were 
homogenized using bead beating technology to lyse the cells. Lysates were loaded 
onto a silica spin filter. During a brief centrifuge spin, the DNA selectively bound to 
the silica membrane while contaminants were passed through. Remaining 
contaminants and enzyme inhibitors were removed by a washing step. Pure DNA was 
then eluted by Tris buffer. 
Five primers including bovine and Y-chromosome specific primers were 
combined and compared for the suitability of multiplex PCR to determine the sex of 
bovine embryos. Primers used in the PCR are shown in Table 3.1. The PCR were 
performed in a total volume of 50 µl containing 1x Green GoTaq® Flexi buffer 
(Promega, USA), 2 mM MgCl2 (Promega, USA), 200 mM of dNTPs, 1 U GoTag® 
DNA polymerase (Promega, USA), 42, 0.42 or 0.0042 ng genomic DNA template and 
each set of primers. The PCR reactions were done in a DNA Thermal cycler for an 
initial denaturation at 95oC for 2 min then followed by 45 cycles of 95oC for 20 sec, 
52oC (BY/BSP), 33 oC (ConBV/ConEY) and 55oC (S4BF/S4BR) for 45 sec and 72oC 
for 50 sec and final extension at 72oC for 10 min. The DNA bands were then 
visualized on 2% agarose gel under an ultraviolet illuminator. 
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Table 3.1 Primers used for bovine embryos sex determination   
 
Couple 
Primer name 
 
 
Primer sequence 
 
Primer 
concentration 
(µM) 
 
Size of 
amplicon 
BSP* 
 
5’-TTTACCTTAGAACAAACCGAGGCAC-3’ 
5’-TACGGAAAGGAAAGATGACCTGACC-3’ 
0.3 
0.3 
538 bpB 
BY* 
 
5’- CTCAGCAAAGCACACCAGAC-3’ 
5’-GAACTTTCAAGCAGCTGAGGC-3’ 
0.5 
0.5 
  300 bpF 
ConBV** 
 
5’-TGGAAGCAAAGAACCCCGCT-3’ 
5’-TCGTCAGAAACCGCACACTG-3’ 
0.5 
0.5 
216 bpB 
ConEY** 
 
5’-GATCACTATACATACACCACT-3’ 
5’-GCTATGACACAAATTCTG-3’ 
0.5 
0.5 
 181 bpF 
S4BF*** 
S4BR*** 
5’-CAAGTGCTGCAGAGGATGTGGAG-3’ 
5’-GAGTGAGATTTCTGGATCATATGGCTACT-3’ 
0.5 
0.5 
145 bpB 
  174 bpF 
B Bovine specific product. F Male specific product. * Reed et al., 1989; Iwata et al., 
2002; Iwata et al., 2008. ** Plucienniczak et al., 1982; Machaty et al., 1993. *** 
Rivière-Dobigny et al., 2009; Kageyama et al., 2004. 
 
3.12  Embryos collection  
The arrested embryos in each stage and blastocyst stage embryos were 
collected at each time period. Zona pellucida of the embryos was removed by 0.5% 
protease and then embryos were washed in PBS. Single embryo was transferred into a 
microcentrifuge tube, and stored in 10 µl RNAse and DNAse-free distilled water at     
-20 oC until used. 
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3.13  Embryos sex determination 
 The frozen embryos from IVF using sexed-sperm were lysed by boiling at 100 
oC for 5 min. The lysed embryos were cooled on ice and mixed by vortex then 5µl of 
boiled embryo were used as template for each 25 µl of multiplex PCR reaction. The 
Y-chromosome specific primers (BY) and bovine specific primers (BSP) were used to 
determine the sex of embryos at various stages. The PCR reaction and PCR product 
bands detection were done as described in the section 3.4 except for the amount of 
template used.  
 
3.14  Statistical analysis 
Data of cleaved embryos and embryo development were analyzed by one-way 
ANOVA using SAS program. Four replications of each experiment were performed. 
 
.  
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CHAPTER IV  
RESULTS  
 
4.1 Monoclonal antibody production 
X63-Ag8.635 myeloma cell line (Figure 4.1) was cultured in cRPMI for 2 
weeks at 37oC in a humidified atmosphere of 5% CO2 in air before the fusion step. 
After 2 BALB/c mice were immunized with bovine Y-sperms, the spleen cells were 
fused with the myeloma cells at the ratio of 6.4:1 to produce hybridoma cells (Figure 
4.2). At day 7-10, small colonies of hybridoma cells can be seen (Figure 4.3). More 
than 2,000 hybridoma colonies were grown in 24 well tissue culture plates before the 
screening step. The cultured media were used as an antibody to determine the 
specificity of secreted antibody on bovine Y-sperms. 
 
 
 
 
 
 
Figure 4.1  X63-Ag8.635 myeloma cell line cultured at day 9   
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Figure 4.2  Fusion of spleen cells and myeloma cells using PEG-4000. The dotted 
arrows indicate the fused myeloma-myeloma cell. The black arrow 
indicate fused myeloma-spleen cell 
 
 
 
 
 
 
 
Figure 4.3   Hybridoma colonies grown on plates at day 7-10.  
  For the 1st screening, unsexed-sperms and egg yolk were used as antigents. The 
results showed that secreted antibodies from hybridoma cells from 17 wells bound 
only sperms and not egg yolk and 16 wells bound both sperms and egg-yolk. Limiting 
dilution method was done using these 33 hybridoma wells. Only 12 hybridoma plates 
from the 33 plates were grown without any contamination. Five plates from the 12 
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plates were selected for the 2nd round of ELISA because the antibodies from these 5 
plates bound only sperms not egg yolk in the 1st ELISA step. From the 480 wells of 
the five 96 well tissue culture plates, only 288 monoclones bound only unsexed-
sperms and not egg yolk in the 2nd round of ELISA screening. All monoclones were 
transferred to new culture medium in 24 wells tissue plates and grown for 2 weeks 
before rescreening with Y- and unsexed-sperms. In the 3rd round of ELISA screening, 
Y- and unsexed-sperms were used as antigens. Only 96 wells from plate G16 showed 
higher OD value to Y-sperms than unsexed-sperms. Seventeen wells were randomly 
selected to rescreen with Y- and X-sperms (7 wells from plate G16 and 10 wells from 
other plates) in the 4th round of ELISA screening. Only mAb produced from 3 
monoclone wells from plate G16 bound specifically to only Y-sperms in the 4th round 
of ELISA screening. Antibodies from these three wells from plate G16 were used to 
confirm the specificity to Y-sperms by observed the binding on Y-sperms surface 
under fluorescence stereo microscopy. The results indicated that the antibody from the 
3 wells from the plate G16 bound only the Y-sperms surface (figure 4.4). They were 
named G16G14, G16E7 and G16E8. From the ELISA screening and the binding of 
sperms surface results indicated that the three produced mAbs were specific to only Y-
sperms without cross-reaction with egg yolk and bovine X-sperms.  
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A 
 
A                                                                                                                 
 
 
 
 
 
 
 
 
Figure 4.4  mAb binding on the bovine Y-sperm surface. White arrows indicate the position that mAb bound on the bovine Y-sperms 
surface. Bovine Y-sperms after mAb binding experiments under light microscope (A, C and E). Bovine Y-sperms after mAb
  
A 
B 
E 
D 
C 
F 
 
binding experiments under fluorescence microscope (B, D and F) 
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4.2  Monoclonal antibody characterization 
4.2.1 Sodium dodecly sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
  The molecular weight of the three purified mAbs, G16G14, G16E7 and 
G16E8 were determined by SDS-PAGE. After the electrophoresis and gel staining, 
very sharp band can be seen at ~66 kDa as (Figure 4.5A). 
 
4.2.2 Western blotting 
To determine the molecular weight of 3 purified mAbs, the proteins 
from unstained gel obtained from SDS-PAGE were transferred to nitrocellulose 
membrane using semi-dry transfer chamber at constant 400 mA for 2 hrs. The sizes of 
both heavy and light chains were detected using alkaline phosphatase reaction. The 
Western blot results indicated that the molecular weight of the heavy and light chain 
were ~66 and ~24 kDa as shown in Figure 4.5B. The results indicated that the 
molecular weight of the 3 purified mAb were ~180 kDa (2 heavy chains × 66 kDa) + 
(2 light chains × 24 kDa). 
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          kDa 
 
 
 
 
 
 
 
 
 
 
Figure 4.5  SDS-PAGE and Western bolt. A 12 % SDS-PAGE gel of the 3 purified mAbs. The goat anti-mouse Ig was used as control 
(A). Western blot of 3 purified mAbs and the goat anti-mouse Ig was used as control (B). Lane M; protein marker, 1; 
116              G14            E8             E7             E7                                C                             G14            E8              E7             E7                             C 
 
 
66.2                                                                                                                                                                                                                                             ~66 
  
45 
 
 
35 
 
 
25                                                                                                                                                                                                                                               ~24  
 
 
18.4 
     M              1               2                3                4               5                 6                M               1                2               3               4                5               6 
 
A B 
G16G14, 2; G16E8, 3-4; G16E7 and C; the goat anti-mouse Ig as a control 
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4.2.3 Monoclonal antibody isotype and subtype identification 
  The isotype and subtype of produced mAb were identified using 
ImmunoPure® MAb Isotyping Kit II. The results demonstrated that all 3 clones, 
G16G14, G16E7 and G16E8 were IgG2a with kappa light chain. 
 
4.3 The effects of guinea pig complement concentrations and 
incubation time on sperm survival 
Three concentrations of guinea pig complement were used to determine the 
effect on sperm survival. The results showed that guinea pig complement at final 
concentration of 2% was the most suitable concentration that did not affect the sperm 
survival (Table 4.1). 
 
Table 4.1  Effect of guinea pig complement on sperm survival 
  
+ = amount of survived sperm 
-  = no survived sperm 
 
Guinea Pig Complement 
final concentration at (%) 
 
Sperm survival 
 
15 min 
 
30 min 
0 ++++++ ++++++ 
2 ++++++ ++++++ 
5 ++ + 
10 - - 
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The most suitable time of guinea complement incubation time were 
determined. Numbers of survived sperms were not different between each incubation  
time of 15, 30 and 45 min (Table 4.2). 
 
Table 4.2 Effect of guinea pig complement on sperm survival 
Guinea Pig Complement 
(final concentration) 
Incubation Time 
(min) 
 
Sperm survival 
 
2% 
15 ++++++ 
30 ++++++ 
45 ++++++ 
 
+ = amount of survived sperm 
4.4 Sperm sexing and In vitro fertilization 
Sperm sexing was done by adding 40 µl of each purified mAb G16G14 (18.1 
mg/ml), G16E7 (32.5 mg/ml) and G16E8 (10.9 mg/ml) to 2 ml TALP and 100 µl 
bovine sperms (25 ×106 sperms/ml) were added. The cytotoxicity reaction was done 
using 2% guinea pig complement incubated at 38.5oC in an atmosphere of 5% CO2 in 
air for 45 min. After the cytotoxicity reaction, the concentration of sexed sperm was 
adjusted to 4 × 106 sperms/ml and was used at 100 µl/20 oocytes in IVF. The sperm 
sexing of each mAb was done 4 times with 50 oocytes/time. The arrested embryos in 
each stage and blastocyst stage embryos were collected at each time period. The 
embryos developments of each sperm sexing treatment are shown in Table 4.3, 4.4, 
4.5 and 4.6. 
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Table 4.3  Development of IVF derived embryos obtained from sexed-sperm using 
G16G14 mAb at 1:50 dilution  
 
No. of 
oocytes 
cultured 
No. (%) embryos 
developed at d 2 
 
No. (%) embryos 
developed to  
 
  Cleaved >4 Cell Morula Blastocyst 
50 35 (70) 17 (34) 5 (10) 2 (4) 
50 29 (58) 15 (30) 5 (10) 1 (2) 
50 31 (62) 14 (28) 4 (8) 4 (8) 
50 30 (60) 19 (38) 2 (4) 6 (12) 
 
Table 4.4  Development of IVF derived embryos obtained from sexed-sperm using 
G16E7 mAb at 1:50 dilution 
 
No. of 
oocytes 
cultured 
No. (%) embryos 
developed at d 2 
 
No. (%) embryos 
developed to  
 
  Cleaved >4 Cell Morula Blastocyst 
50 21 (42) 14 (28) 3 (6) 1 (2) 
50 11 (22) 7 (14) 4 (8) 1 (2) 
50 21 (42) 14 (28) 2 (4) 5 (10) 
50 19 (38) 13 (26) 3 (6) 5 (10) 
  
Table 4.5  Development of IVF derived embryos obtained from sexed-sperm using 
G16E8 mAb at 1:50 dilution 
 
No. of 
oocytes 
cultured 
No. (%) embryos 
developed at d 2 
 
No. (%) embryos 
developed to  
 
Cleaved >4 Cell Morula Blastocyst 
50 16 (32) 10 (20) 1 (2) 3 (6) 
50 16 (32) 14 (28) 0 4 (8) 
50 22 (44) 12 (24) 1 (2) 3 (6) 
50 30 (60) 19 (38) 6 (12) 3 (6) 
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Table 4.6  Development of IVF derived embryos obtained from unsexed-sperm 
(control) 
 
 
No. of 
oocytes 
cultured 
                       
No. (%) embryos 
developed at d 2 
 
No. (%) embryos 
developed to  
 
  Cleaved >4 Cell Morula Blastocyst 
50 31 (62) 17 (34) 3 (6) 3 (6) 
 
The embryos development between IVF derived embryos obtained from sexed- 
sperms and unsexed-sperms was not significantly different. The percent of cleaved 
and blastocyst stage embryos were very low because at the experimental period time, 
the qualities of oocytes were low.  
 
4.5 Multiplex polymerase chain reaction (PCR) optimization for 
embryo sex determination (published in Rattanasuk et al., 2011) 
Five primers including bovine and Y-chromosome specific primers were 
combined and compared for the suitability of multiplex PCR to determine the sex of 
bovine embryos. The multiplex PCR conditions for three couple primers were 
optimized using extracted genomic DNA from male and female bovine fibroblasts as 
template. The results indicated that only BY/BSP couple primers (Figure 4.6) were 
able to identify the sex of the bovine DNA without any unexpected bands on gel. 
Minimum amount of bovine DNA appropriate for amplification using BY/BSP couple 
primers was 0.42 ng/50 µl reaction (Figure 4.7). To confirm the accuracy of BY/BSP 
couple primers, this couple primers were used to determine one-cell, two-cell, four-
cell and eight-cell stage embryos of known sexed of somatic cell nuclear transfer 
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(SCNT) derived embryos, the results showed 100% accuracy (Figure 4.8 and 4.9). 
From the experiment indicated that BY/BSP couple primers were able to identify sex 
of IVF derived embryos. However, the 300-bp band of BY primer was not as intense 
due the primer concentration used in this experiment. The couple primers 
concentration were optimized by varying the BY/BSP at 5:1, 5:2 and 5:3 (Figure 
4.10). The results indicated that the most optimal primer concentrations used for 
multiplex BY/BSP primer were BY primer 0.5 µM and BSP primer 0.3 µM, (5:3).  
 
 
 
 
 
 
 
 
 
 
Figure 4.6  PCR results of three different couple primers specific for bovine and 
male bovine. M: size marker, ♂: male bovine genomic DNA (0.42 ng); 
♀: female bovine genomic DNA (0.42 ng). Only BY/BSP couple primers 
were able to amplify and demonstrate clear results  
 
 
         BY/BSP         S4BF-S4BR             ConBV              ConEY      
          M         1           2           3          4              5            6            7            8   
                      ♂         ♀          ♂         ♀            ♂            ♀            ♀          ♂    
                             
  
 
                  538   bp           
 
                      300 bp  
                                                      216 bp          
                                            178 bp                                                                           181 bp       
                    145bp 
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A 
 
 
                                                                                                                                         
 
 
Figure 4.7 PCR sensitivity using BY/BSP primers. M : size marker; Lane 1-3: male 
bovine genomic DNA (42, 0.42 and 0.0042 ng). land 4-6: female bovine 
genomic DNA(42, 0.42 and 0.0042 ng) 
 
 
 
 
 
 
 
 
 
 
 
    M              1                2               3                4              5            6 
538 bp 
300 bp 
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Figure 4.8 Confirmation of BY/BSP couple primers using SCNT female embryos at 
various stages as templates.  M: DNA size marker; lane 1-11: SCNT 
female embryos; lane 12: (-) control; lane 13: female bovine genomic 
DNA (0.42 ng) and lane 14: male bovine genomic DNA (0.42 ng), 
respectively. The stages of embryo are shown by the number under the 
figure. 1: one-cell, 2: two-cell, 4: four-cell and 8: eight-cell stages 
 
 
 
 
 
 
 
    M      1      2      3      4      5       6      7      8      9    10    11     12     13      14      
 
            ♀     ♀     ♀     ♀      ♀     ♀     ♀     ♀     ♀     ♀     ♀               ♀     ♂ 
                                                                                                    
                                                                                                                                                          538 bp       
                                                                                                                                                                             300 bp  
 
1      4       4       2      2      4      4      4      8     4      4       embryo stages 
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Figure 4.9 Confirmation of BY/BSP couple primers using SCNT male embryos at 
various stages as templates.  M: DNA size marker; lane 1: female 
bovine genomic DNA (0.42 ng) and lane 2: male bovine genomic DNA 
(0.42 ng); lane 3-7:  SCNT male embryos, respectively. The stages of 
embryo are shown by the number under the figure. 1: one-cell, 2: two-
cell, 4: four-cell and 8: eight-cell stages 
 
 
 
 
 
 
 
 
     M             1              2             3             4              5             6             7            
 
 
 
                      ♀         ♂        ♂        ♂        ♂        ♂        ♂ 
    1            2             8             4              4         
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Figure 4.10  Optimal primer concentrations used for multiplex BY/BSP primer. M:        
DNA size marker; 5:1, 5:2 and 5:3 of BY:BSP primer concentration 
ratio 
 
4.6 IVF derived embryos sex determination and development 
 Six hundred IVF derived embryos were used as template in multiplex PCR to 
test the accuracy and precision of the sexed sperms treated with the produced mAbs. 
Figure 4.11 showed the sample result of arrested at 2 cell embryos sex determination 
obtained from IVF using sexed sperms treated with G16E8 mAb. In lane 1; water was 
used as negative control and lane 2-23; arrested at 2 cell embryos. The results 
indicated that all arrested at 2-cell embryos were female. Figure 4.12 showed the 
result of arrested at 8-, 32-cell, morula embryos and blastocyst embryos sex 
determination. Lane 1-3: blastocyst stage embryos; lane 4-9: morula stage embryos; 
lane 10-21: 32-cell stage embryos and lane 22-23: 8-cell stage embryos. The results
M                             5:1                     5:2                       5:3 
538 bp 
                     300 bp 
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 indicated that female sex ratio of blastocyst stage embryos was 50:50 due to the 
ambiguous band in lane 1. Sex results from lane 1 were not used to calculate the sex 
ratio. 
 The female sex ratios of each stage of IVF derived embryo are shown in Figure 
4.13. The results indicated that the 2-cell stage embryos showed higher female sex 
ratio when compared with all other embryo stages. In contrast, the blastocyst stage 
embryos contained lowest female sex ratio. The average female sex ratio between 
G16G14, G16E7 and G16E8 were 78.4+3.9, 74.4+1.5 and 76.0+8.9, respectively 
which were not significantly different among treatments. 
 The IVF derived embryos development was observed and the results showed 
that the percent of cleaved IVF derived embryos was separated into 2 groups, sperms 
treated with G16G14 mAb and control group were not significantly different but 
significantly difference from the sperm treated with G16E7 and G16E8 mAb groups 
(Table 4.7). The factors that might affect embryos development can be sperms health 
and the fertilization efficiency. However, the percent cleaved of IVF derived embryos 
of sexed sperm treated with G16G14 mAb was not significantly different to the 
control. In contrast, the percent of cleaved IVF derived embryos of sexed sperm 
treated with G16E7 and G16E8 mAb were lower than control. The quality of oocytes 
used for IVF might also be the reason for low percent cleaved embryo. During the 
time of their experiments some days the quality of oocyte was low. 
 The results suggested that G16E7 mAb gave the highest efficient mAb used for 
sperm sexing. The values of embryo sex from sperm treated the 3 mAb were similar, 
but G16E7 mAb has the lowest standard deviation. Female sex ratio of the embryos 
obtained from sperm treated with G16G14 and G16E8 mAb was higher than G16E7 
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mAb, but the standard deviation were also higher. The G16E7 mAb was used to 
confirm the effect of sperm sexing using mAb for embryo development (Table 4.8). 
The results indicated that the sperm sexing using mAb did not show negative effect to 
the embryo development.  
 
 
 
 
 
 
 
 
Figure 4.11 IVF derived embryos at 2-cell stage sex determination by the BY/BSP 
based PCR method. M: 100 bp DNA size marker. Lane 1: negative 
control; Lane 2-23: 2-cell IVF-derived embryos obtained from sexed 
sperm treated with G16E8 mAb 
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Figure 4.12 IVF derived embryos sex determination by the BY/BSP based PCR 
method. M: 100 bp DNA size marker. Lane 1-23: day 4 and day 8 IVF-
derived embryos obtained from sexed sperm using G16E8 mAb 
replicated 4   
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Table 4.7 Embryo development of IVF embryo fertilized with G16G14, G16E7 and 
G16E8 mAb treated sperms and untreated (control)  
 
Values with different superscript within each column are significantly different 
(P<0.05)  
 
 
 
 
 
 
 
 
Treatments 
 
 
 
No. of 
oocytes 
culture 
 
No. (%) embryos 
developed at d 2 
 
 
No. (%) embryos 
developed to 
 
 
Cleaved (%)
 
> 4 cell (%)
 
 
Morula 
(%) 
 
Blastocyst 
(%)
 
G16G14 
 
200 
 
125 (62.5)a 
 
65 (32.5) 
 
16 (8) 
 
 
13 (6.5) 
 
 
G16E7 
 
200 
 
75 (37.5)b 
 
48 (24) 
 
12 (6) 
 
 
12 (6.0) 
 
 
G16E8 
 
200 
 
84 (42)b 
 
55 (27.5) 
 
8 (4) 
 
 
13 (6.5) 
 
 
Control 
 
50 
 
31 (62)a 
 
17 (34) 
 
3 (6) 
 
 
3 (6.0) 
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Table 4.8  Embryo development of IVF embryo fertilized with G16E7 mAb treated 
sperms and untreated (control)  
 
Treatment 
 
No. of 
oocytes 
culture 
Day 2 Day 8 
 
Cleaved 
(%) 
 
> 4 cell 
(%) 
 
 
Morula 
(%) 
 
Blastocyst 
(%) 
G16E7 1 24 22 (91.7) 16 (66.7) 5 (20.8) 5 (20.8) 
G16E7 2 28 20 (71.4) 15 (53.6) 7 (25.0) 7 (25.0) 
G16E7 3 28 22 (78.6) 17 (60.7) 7 (25.0) 7 (25.0) 
G16E7 4 28 22 (78.6) 17 (60.7) 8 (28.6) 8 (28.6) 
G16E7 5 28 22 (78.6) 17 (60.7) 9 (32.1) 9 (32.1) 
G16E7 
Total 
136 108 (79.4) 82 (60.3)a 36 (26.5) 36 (26.5) 
Control 1 26 22 (84.6) 14 (53.8) 5 (19.2) 5 (19.2) 
Control 2 28 21 (75.0) 14 (50.0) 8 (28.6) 7 (25.0) 
Control 3 28 21 (75.0) 15 (53.6) 8 (28.6) 8 (28.6) 
Control 4 28 20 (71.4) 15 (53.6) 8 (28.6) 8 (28.6) 
Control 5 28 20 (71.4) 15 (53.6) 8 (28.6) 8 (28.6) 
Control 
Total 
138 106 (76.8) 73 (52.9)b 37 (26.8) 36 (26.0) 
 
Values with different superscript within each column are significantly different 
(P<0.05)  
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Figure 4.13 Percent of female embryos at different stages of arrested embryos and 
blastocyst 
  *; arrested 2 cell stage embryos 
**; > arrested 4 cell stage embryos 
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CHAPTER V                                                           
DISCUSSION 
 
The immunological method is the method that does not affect the unbound 
sperms. The mAb production from this works focused on the surface protein of bovine 
Y-sperms. In contrast, many researches focused on H-Y antigen (Ali et al., 1990: 
Hendriksen et al., 1993; Patthanawong et al., 2010; Peter et al., 1993; Bradley, 1989; 
Benjamin et al., 2002; Bryant, 1980; Bryant, 1984.). However, few reports on surface 
protein have also been found (Ambrose et al., 1996; Spaulding, 1997). In 1984, Hoppe 
and Koo (1984) found that they were unable to enrich the sperm sex ratio using 
antibodies against the H-Y antigen.  The failure of this method might be from the 
mistake of the underlying theory. Garner (1984) found that H-Y antigen was 
expressed as an integral membrane protein, Y-sperm did not produce H-Y themselves 
but both X- and Y-sperms adsorbed H-Y antigen to their surface. Hope and Koo 
(1984) also found the both X- and Y-sperms reacted with the anti H-Y antibody. The 
experimental technique of each investigator that found that the H-Y is expressed only 
on Y-sperms may have been a flaw. From these evidences, we decided to produce 
mAb against surface protein of bovine Y-sperm not the H-Y antigen.  
The X63.Ag8.635 myeloma cell line used in this experiment obtained from 
Department of Immunology, Siriraj Hospital, Mahidol University. This myeloma cell 
line was recommended for mAb production by Kearney et al. (1979) because this cell 
line does not secrete any antibody by itself. This cell line has been used by many 
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researches (Millán et al., 1982; Carlsson et al., 1985; Shiels et al., 1986; Treanor et al. 
1988; Sundström et al., 1989; Dungan and Roberson, 1993; Poudrier and Owens 
1995; Lin and Hünig, 2003; Fayemi, 2004; Fujii et al., 2004; Hifumi et al., 2008; 
Patthanawong et al., 2010). Other type of myeloma cell lines such as NS1/1.Ag4 
(Stern et al., 1978; Dráber et al., 1980; Russell et al., 1981; Slovin et al., 1982; Hosoi 
et al., 1982; De Boer and Wieczorek, 1984; Shone et al., 1985; Ambrose et al., 1996; 
Hifumi et al., 2008; Ning et al., 2012), Sp2/0-Ag14 (Köhler et al., 1976; Köhler, 
1985; Dungan and Roberson, 1993; Sugaya et al., 1997; Mallory et al., 2007) have 
also used in many researches. 
In the fusion step, the ratio of immunized mouse spleen and myeloma cells 
might affect the number of positive clones obtained. Ambrose et al. (1996) and 
Patthanawong et al. (2010) fused spleen cells with myeloma cell at the ratio of 1:5. 
The hybridoma Cloning Kit (Technical manual) also recommended 1:5 spleen cells to 
myeloma cells (http://www.stemcell.com/~/media/Technical%20Resources/9/3/F/0/1/ 
28411_MAN_2_2_0.ashx). But some protocols recommend 2 spleen cells:1 myeloma 
cell (people.rit.edu/~gtfsbi/hytc/20103HyTcWeek2.ppt, Fayemi, 2004). The fusion 
step in this experiment was done using ratio of spleen cells per myeloma cell of 6.4:1. 
More than 2,000 hybridomas were obtained from this fusion. Only 148 hybridomas 
were obtained from Patthanawong et al. (2010) when 1:5 spleen cells with myeloma 
cell were used. The amount of hybridomas obtained from each fusion might depend 
on the ratio and number of spleen and myeloma cell.  
The screening step is the most important step for the mAb production. The 
antigen used in this step affected the specificity of mAb, if unspecific antigen was 
used in this step, low specificity mAb might be obtained. In this research 3 steps of 
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screening were done. We found that the errors of ELISA increase when the screening 
procedure was repeated. In the 1st step, the hybridomas cultured supernatants were 
screened for the specificity against unsexed bovine sperms using egg yolk as negative 
control. After that, the positive antibody producing-hybridomas were selected and 
transferred into new media to increase the amount of selected hybridomas. The 2nd 
step, the positive hybridoma cultured supernatant were determined its specificity 
against bovine X- and Y-sperms. In the 3rd step the cultured supernatant of the 
selected hybridomas were used to check the specificity by sperm surface binding.  The 
produced mAbs from this research believed to be specific to bovine Y-sperms. 
However, other researches normally screen their mAbs in only one or two steps 
(Ambrose et al., 1996; Patthanawong et al., 2010; Chakraborty et al., 1985).  
The isotype of the 3 mAbs from this research were IgG with κ light chain. 
That is in agreement with the general corrected antibody isotype in the immune 
response. For the 1st injection, IgM is a primary antibody response produced and the 
secondary antibody response, IgG is also produced, but the concentration is lower 
than IgM (Figure 5.1). For the 2nd and 3rd injection with the same antigen, the IgM 
will be lower and the IgG is the predominant antibody (Roitt et al., 2001).     
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Figure 5.1  Primary and secondary antibody response (http://nfs.unipv.it/nfs/minf        
/dispense/immunology/lectures/files/somatic_hypermutation.html) 
 The MW of the three mAbs produced in this research was check using SDS-
PAGE and Western blotting. IgG is the monomeric type which containing 2H2L. 
From the results of SDS-PAGE, a very sharp band can be seen at ~66 kDa (Figure 
4.5A). The results from Western blotting showed that MW of the heavy and light 
chains were ~66 kDa and ~24 kDa. The Figure 4.5B, after finished the Western blot 
experiment, two bands can be seen but after that the lower band faded away. The 
results from both methods indicated that the MW of 3 mAbs were ~180 kDa. Cruz et 
al. (2002) found the IgG obtained from their research was ~180 kDa. 
 The three produced mAbs against bovine Y-sperms were used for bovine 
sperm sexing. Y-sperms were destroyed using guinea pig complement via the 
cytotoxicity reaction. This research determined the effect of guinea pig complement 
concentration and incubation time used for sperm sexing. The results found that final 
concentration of 2% guinea pig complement and 45 min for incubation time at 38.5oC 
under humidified atmosphere of 5% CO2 in air were the suitable for sperm sexing 
using the produced mAbs. In 2002, Matta (US Patent No. 20020115055) claimed the 
method used for sperm sexing by incubating heated guinea pig serum with sperm cells 
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and mAbs. He claimed that the sperm cells were incubated with mAbs for 45 min at 
37oC followed by washing and adding the serum and then incubating for 1 hr at 37oC. 
Our research here did not inactivate the guinea pig complement. The US Patent No. 
20020115055 claimed that inactivated guinea pig complement at 52.2oC for 30 min 
before used will eliminated the B protein potentially originated from the peritoneal 
macrophage that will affect the alternative pathway of guinea pig complement (de 
Resende Matta, 2002). In their experiment no the mAb concentration was reported. 
Our research, the sperms sexing was combined with the sperm separation using swim 
up method. The sperms cells were incubated with TALP containing mAb for 20 min 
before adding guinea complement and then incubated for 45 min at 38.5oC under 
humidifoed atmosphere of 5% CO2 in air. The total sexing process time is 65 min. 
Jamil et al. (2007) reported only 30 min in the sperm swim-up procedure, but in our 
research 65 min was used because the suitable time for guinea pig complement was 
done followed the product information of 60 min. From de Resende Matta (2002) 
results showed that 308 IVF derived embryos analyzed, 244 (79.2%) were female, but 
in our research, found 157 from 200 (78.4%) IVF derived embryos were found to be 
female.  
The development of IVF derived embryos obtained from sexed sperm (Table 
4.3, 4.4 and 4.5) and unsexed sperms (Table 4.6) were not significantly different, but 
the result showed that the percent of cleaved and blastocyst embryos were very low 
when compared with Sripunya et al., 2010. The low number of blastocyst 
development was due to the oocytes quality obtained during Oct-Dec 2011. The 
oocytes quality used in the embryo development study between each sexed sperm 
obtained from 3 mAbs were low. Therefore, the G16E7 mAb was selected to confirm 
  
 
 
 
 
 
 
72 
 
the development during the season of better oocytes (April 2012). The result indicated 
that the sperm sexing experiment does not affect to the IVF derived embryo obtained 
from sexed sperms (Table 4.8) and the percent of blastocyst was higher than previous 
experiments. 
The embryo sex determination is important for manipulating the sex ratio of 
domestic animals (Handyside et al., 1989; Penketh et al., 1989). Many approached 
have been used to determine the sex of bovine embryos but failed to gain much 
popularity due the lack of either accuracy or speed (Van Vliet et al., 1989). To solve 
the problem, this research combined several PCR primers, one for bovine specific 
primer and another for male bovine specific primer, to examine as multiplex PCR 
(Rattanasuk et al., 2011). PCR has been used for embryo sexing with various target 
sequences, including male-specific repetitive sequence (Bredbacka et al., 1995; 
Schroder et al., 1990), ZFY gene (Aasen and Medrano, 1990; Krikpatrick and 
Monson, 1993; Kudo et al., 1993) and single-copy genes on the Y-chromosome such 
as amelogenin (Chen et al., 1999; Ennis and Gallagher, 1994). The results from the 
IVF derived embryo obtained from G16G14, G16E7 and G16E8 mAbs treated-sperms 
were 78.4+3.9, 74.4+1.5 and 76.0+8.9 female, respectively which were not 
significantly difference among treatments but higher than the 50% in control.  
Machaty et al., 1993 reported that they used two sets of PCR primer, Y-
chromosome specific primers (300 bp) and bovine specific satellite sequence primers 
(216 bp) and Kitiyanant et al., (2000) also used the same primers. Their PCR product 
sizes were very close and found that some PCR product bands were not sharp and 
clear. These problems affected the interpretation of the result and if compared with 
this work, 538 bp and 300 bp, the PCR product bands were separate good enough,  
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with very sharp and clear bands. 
 Cong-Ying et al. (2004) reported two pairs of nested primers used to 
determine the bovine pre-implantation embryos, derived from the 5’ flanking 
sequence of the bovine SRY gene (male specific primer) and casein protein gene 
primer (internal control). The nested PCR used in their experiment take longer time 
than multiplex PCR used in this research.  
Lemos et al. (2005) and Jinming et al. (2007) reported that they designed 
primer for TSPY (male specific primer) and microsatellite DNA (both sex). In their 
experiment they did not combined the two primers set together so one sample must 
used 2 reactions, male and microsatellite which will cost higher when compared with 
multiplex PCR in this research. Some researchers also used Y-specific sequence to 
screen blood, meat and blastomere sample (Zeleny et al., 2002; Alves et al., 2003). 
 Ekici et al. (2006) designed primers used for bovine embryos sex 
determination using PCR. The bovine Y-chromosome and bovine G3PDH gene were 
selected. The PCR product sizes of these couple primer are 279 and 579 bp. However, 
the results from their reported found some unspecific bands and smear bands. 
Eggtech company reported that the bovine embryo sexing kit, non-
electrophoretic sex determination of bovine pre-implantation embryos, is simplest and 
fastest PCR-based method, convenient for embryo sexing on farm, low cost, no need 
for electrophoresis, minimal risk of contamination, but only 95% accuracy can be 
obtained from this kit (http://www.egg tech.co.uk/ resources/Finnzymes%20Ampli-
Y.pdf). 
Multiplex PCR is a rapid, easy method for large scale embryos sexing. This 
couple primers (BY/BSP) has been used to determine the sex of somatic nuclear 
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transfer (SCNT) and IVF derived embryos in various stages. The results showed 
100% accuracy (Rattanasuk et al., 2011).  
 In conclusion, this research successfully produced 3 mAbs against bovine Y-
sperms that is important for bovine sperm sexing. The sperms treated with these mAbs 
did not effect to embryo development of the used in IVF. And more that 70% of IVF 
embryos obtained were shown to be female embryos. The multiplex PCR from this 
work will also benefit the field of bovine embryo sexing by using multiplex PCR. 
 
  
 
 
 
 
 
 
CHAPTER VI                                                      
CONCLUSION 
 
 Two BALB/c mice were immunized with mixed bovine Y-sperms and 
Complete Freund's Adjuvant for the 1st injection and 2 boosts with mixed Y-sperms 
and Incomplete Freund's Adjuvant. Three mAb (G16G14, G16E7 and G16E8) against 
bovine Y-sperm were produced. The specificity of G16G14, G16E7 and G16E8 was 
determined using ELISA and confirmed by observed the binding on Y-sperms 
surface. Molecular weight of each mAb was determined by western blot, the 
molecular weight of each mAb is approximately 180 kDa. The mAb isotype and 
subtype of the 3 mAbs were IgG2a with κ light chain. The produced mAbs were used 
to determine the effect on sperm survival by varied the final concentration of guinea 
pig complement and incubation time.  The most suitable condition was used for sperm 
sexing. The sexed sperms were used in IVF experiment. The result indicated that the 3 
mAbs altered the sex ratio by increasing the female sex ratio to 78.4, 74.4 and 76.0%. 
The G16E7 mAb is the most efficiency mAb used for sperm sexing because of the 
standard deviation between each group was low. Finally, this work successfully 
produced mAb against bovine Y-sperm that is important for sperm sexing. 
 
  
 
 
 
 
 
 
76 
 
REFFERENCES 
 
http://biochemistryquestions.wordpress.com/2009/05/26/immunoglobulins-structure-       
and-functions/                          
http://biology.about.com./od/basicgenetics/p/chromosgender.htm  
http://pathmicro.med. sc.edu/mayer/igstruct2000.htm                                     
http://www. rosenthallab.com/gallery/detail.php?fileName=antibody.GIF  
http://www.eggtech.co.uk/resources/Finnzymes%20Ampli-Y.pdf  
http://www.fao.org/DOCREP/004/T0120E/T0120E07.htm  
http://www.geochembio.com/biology/organisms/cattle/cattle-life-cycle.html  
http://www.gpo.or.th/rdi/html/Flow-cytometry.html   
http://www.nobelprize.org/nobelprizes/medicine/ laureates/1984/speedread.html  
http://www.pc.maricopa.edu/Biology/rcotter/BIO%20205/LessonBuilders/Chapter%2
015%20LB/Ch15LessonBuilder_print.html  
http://www.research.uci.edu/ora/acup/freundsadjuvant.htm  
http://www.stemcell.com/~/media/Technical%20Resources/9/3/F/0/1/28411_MAN_2
_2_0.ashx                                                                 
http://www.virology.ws/2009/07/22/adaptive-immune-defenses-antibodies/      
http://www.who.int/topics/immun ization/en  
people.rit.edu/~gtfsbi/hytc/20103HyTcWeek2.ppt      
Aasen, E. and Medrano, J.F. (1990).  Amplification of the ZFY and ZFX genes for sex  
 
  
 
 
 
 
 
 
77 
 
identification in humans, cattle, sheep and goats. Biotechnology 8:1279-1281. 
Adimoelja, F.X.A. (1984). Separation of X-spermatozoa with the Sephadex Gel 
Filtration Method for Female Sex Preselection. Surabaya. 
Adimoelja, F.X.A. (1987). Sephadex gel for sex preselection. In New Horizons in 
Sperm Cell Research (Ed. H. Mohri.) (pp. 491-499). Gordon and Breach 
Science Publishers, New York. 
Ali, J., Eldridge, F., Koo, G. and Schanbacher, B. (1990). Enrichment of bovine X-and 
Y-chromosome-bearing sperm with monoclonal H-Y antibody-fluorescence-
activated cell sorter. Systems Biology in Reproduction Medicine 24(3): 235-
245. 
Ambrose, J.D., Rajamahendran, R., Yoshiki, T. and Lee, C.Y. (1996). Anti-bull sperm 
monoclonal antibodies: I. Identification of major antigenic domains of bull 
sperm and manifestation of interspecies cross-reactivity. Journal of 
Andrology 17(5): 567-578. 
Andersen, C.Y. and Byskov, A.G. (1997). Enhanced separation of X and Y bearing 
sperm cells by a combined density gradient centrifugation evaluated by 
fluorescence in situ hybridization of the Y-chromosome. Acta Obstetricia et 
Gynecologica Scandinavica 76(2): 131-134. 
Avery, B. and Schmidt, M. (1989). Sex determination of bovine embryos using HY 
antibodies. Acta veterinaria Scandinavica 30(2): 155. 
Bangham, A. (1961). Electrophoretic characteristics of ram and rabbit spermatozoa. 
Proceedings of the Royal Society of London. Series B. Biological Sciences  
155(959): 292-305. 
Beckett, T., Martin, R. and Hoar, D. (1989). Assessment of the sephadex technique for  
  
 
 
 
 
 
 
78 
 
selection of X-bearing human sperm by analysis of sperm chromosomes, 
deoxyribonucleic acid and Y-bodies. Fertility and Sterility 52(5): 829. 
Beernink, F. and Ericsson, R.J. (1982). Male sex preselection through sperm isolation. 
Fertility and Sterility 38(4): 493-495. 
Benjamin, T.L., Kohn, B., Basker, C.J., George, S. and Livingston, D. (2002). Method 
for sex determination of mammalian offspring. United States Patents 
6,153,373. 
Bennett, D. and Boyse, E. A. (1973). Sex Ratio in Progeny of Mice Inseminated with 
Sperm treated with H-Y Antiserum. Nature 246(5431): 308-309. 
Billiau, A. and Matthys, P. (2001). Modes of action of Freund’s adjuvants in 
experimental models of autoimmune diseases. Journal of Leukocyte Biology 
70(6): 849-860. 
Blottner, S., Bostedt, H., Mewes, K. and Pitra, C. (1994). Enrichment of Bovine X and 
Y Spermatozoa by Free‐Flow Electrophoresis. Journal of Veterinary 
Medicine Series A 41(1-10): 466-474. 
Bongso, A., Jarina, A., Ho, J., Ng, S. and Ratnam, S. (1993). Comparative evaluation 
of three sperm-washing methods to improve sperm concentration and motility 
in frozen-thawed oligozoospermic and normozoospermic samples. Systems 
Biology in Reproduction Medicine 31(3): 223-230. 
Bradley, M.P. (1989). Immunological Sexing of Mammalian Semen: Current Status 
and Future Options. Journal of Dairy Science 72(12): 3372-3380.    
Bredbacka, P. and Peippo, J. (1995). PCR-sexing of bovine embryos: a simplified  
protocol. Theriogenology 44:167-176. 
Brunner, M., Jaswaney, V. and Wachtel, S. (1987). Reaction of monoclonal HY  
  
 
 
 
 
 
 
79 
 
antibody in the ELISA. Journal of Reproductive Immunology 11(3): 181- 
191.                                                                                                                               
Bryant, B.J. (1980). Method and material for increasing the percentage of mammalian 
offspring of either sex. United States Patents 4,191,749.  
Bryant, B.J. (1984). Preparation of monospecific male-specific antibody and the use 
thereof for increasing the percentage of mammalian offspring of either sex. 
United States Patents 4,448,767. 
Burgoyne, P.S. (1987). The role of the mammalian Y chromosome in 
spermatogenesis. Development 101(Supplement): 133-141. 
Burgoyne, P.S., Levy, E.R. and McLaren, A. (1986). Spermatogenic failure in male 
mice lacking H-Y antigen. Nature 320(6058): 170-172. 
Carlsson, L., Folkersen, J. and Stigbrand, T. (1985). Antigenic determinants of 
pregnancy-associated α2-glycoprotein and α2-macroglobulin defined by poly- 
and monoclonal antibodies. Molecular Immunology 22(9): 1073-1080. 
Cartwright, E.J., Harrington, P.M. Cowin, A. and Sharpe, P.T. (1993). Separation of 
bovine X and Y sperm based on surface differences, Molecular Reproduction 
and Development 34: 323-328. 
Chakraborty, J., Constantinou, A. and Mc Corquodale, M. (1985). Monoclonal 
antibodies to bull sperm surface antigens. Animal Reproduction Science 9(2): 
101-109. 
Check, J. and Katsoff, D. (1993). A prospective study to evaluate the efficacy of 
modified swim-up preparation for male sex selection. Human Reproduction 
8(2): 211-214. 
Chen, C.M., Hu, C.L., Wang, C.H., Hung, C.M., Wu, H.K., Choo, K.B. and Cheng,  
  
 
 
 
 
 
 
80 
 
W.T. (1999) Gender determination in single bovine blastomeres by polymerase  
chain reaction amplification of sex-specific polymorphic fragments in the 
amelogenin gene. Molecular  Reproduction and  Development 54:209-214. 
Chen, M. J. and Bongso, A. (1999). Comparative evaluation of two density gradient 
preparations for sperm separation for medically assisted conception. Human 
Reproduction 14(3): 759-764. 
Chen, M.J., Guu, H.F. and Ho,E. (1997). Efficiency of sex pre-selection of 
spermatozoa by albumin separation method evaluated by double-labelled 
fluorescence in-situ hybridization. Human Reproduction 12(9): 1920-1926. 
Chodaczek, G. (2004). Adjuvants as factors improving efficiency of vaccination. 
Postȩpy Higieny I Medycyny Doświadczalnej (Online) 58: 47. 
Cong-Ying, C., Lu-Sheng, H., Jing-Bo, C., Neng-Shui, D., Li-Lua, Z. and Hai-Xia, X. 
(2004). Establishing and optimizing the system for sex determination of bovine 
preimplantation embryos. Chinese Journal of Agricultural Biotechnology 
1(01): 13-16. 
Corson, S.L., Batzer, F.R., Alexander, N.J., Schlaff, S. and Otis, C. (1984). Sex 
selection by sperm separation and insemination. Fertility and Sterility 42(5): 
756. 
Cran, D.G., Johnson, L.A. and Polge, C. (1995). Sex preselection in cattle: a field trial. 
Veterinary record 136(19): 495-496. 
Cruz, H.J., Conradt, H.S., Dunker, R., Peixoto, C.M., Cunha, A.E., Thomaz, M., 
Burger, C., Dias, E.M., Clemente, J., Moreira, J.L., Rieke, E. and Carrondo, 
M.J.T. (2002). Process development of a recombinant antibody/interleukin-2 
fusion protein expressed in protein-free medium by BHK cells. Journal of  
  
 
 
 
 
 
 
81 
 
Biotechnology 96: 169-183. 
Cui K.H. (1997). Size differences between human X and Y spermatozoa and 
prefertilization diagnosis. Molecular Human Reproduction 3(1): 61-67. 
Cui, K. H. and Matthews, C. D. (1993). X larger than Y. Nature 366: 117-118. 
De Boer, S. and Wieczorek, A. (1984). Production of monoclonal antibodies to 
Corynebacterium sepedonicum. Phytopathology 74(12): 1431-1434. 
De Jonge, C.J. (1999). Attributes of fertile spermatozoa: an update. Journal of 
Andrology 20(4): 463. 
De Jonge, C.J., Flaherty, S.P., Barnes, A.M., Swann, N.J. and Matthews, C.D. (1997). 
Failure of multitube sperm swim-up for sex preselection. Fertility and 
Sterility 67(6): 1109-1114. 
De Maistre, E., Bene, M., Foliguet, B., Touati, F. and Faure, G. (1996). Centrifugation 
on Percoll gradient enhances fluorescent lectin binding on human sperm: a 
flow cytometric analysis. Systems Biology in Reproduction Medicine 37(3): 
179-187. 
de Resende Matta, M.F. (2002). Gender differentiation of bovine sperm cells. United 
States Patent No. 20020115055. 
de St Groth, S.F. and Scheidegger, D. (1980). Production of monoclonal antibodies: 
strategy and tactics. Journal of immunological methods 35(1-2): 1-21. 
Diasio, R. and Glass, R. (1971). Effects of pH on the migration of X and Y sperm. 
Fertility and Sterility 22(5): 303. 
Dmowski, W.P., Gaynor, L., Rao, R., Lawrence, M. and Scommegna, A. (1979). Use 
of albumin gradients for X and Y sperm separation and clinical experience 
with male sex preselection. Fertility and Sterility 31(1): 52. 
  
 
 
 
 
 
 
82 
 
Downing, D., Black, D., Carey, W. and Delahanty, D. (1976). The effect of ion-
exchange column chromatography on separation of X and Y chromosome-
bearing human spermatozoa. Fertility and Sterility 27(10): 1187. 
Dráber, P., Zikán, J. and Vojtíŝková, M. (1980). Establishment and characterization of 
permanent murine hybridomas secreting monoclonal anti‐thy‐1 antibodies. 
International Journal of Immunogenetics 7(6): 455-474. 
Dungan, C. and Roberson, B. (1993). Binding specificities of mono-and polyclonal 
antibodies to the protozoan oyster pathogen Perkinsus marinus. Diseases of 
aquatic organisms 15(1): 9-22. 
Ekici, H., Turan, N., Sontas, B., Helps, C., Senunver, A. and Yilmaz, H. (2006). Sex 
determination of bovine embryos using polymerase chain reaction (PCR). 
Revue de Médecine Vétérinaire 157(8/9): 441. 
Ennis, S. and Gallagher, T.F. (1994). A PCR-based sex determination assay in cattle 
based on the bovine amelogenin locus. Animal Genetic 25:425-427. 
Epstein, C.J., Smith, S. and Travis, B. (1980). Expression of H‐Y Antigen on 
Preimplantation Mouse Embryos. Tissue Antigens 15(1): 63-67. 
Ericsson, R.J. and Beernink, F. (1987). Letters to the editor. Fertility and Sterility 47: 
531-533. 
 Ericsson, R.J., Langevin, C.N. and Nisho, M. (1973). Isolation of fractions rich in 
human Y sperm. Nature 246: 421-424. 
Evans, J., Douglas, T. and Renton, J. (1975). An attempt to separate fractions rich in 
human Y sperm. Nature 253(5490): 352-354. 
Farber, S., Diamond, L.K., Mercer, R.D., Sylvester, R.F. and Wolff, J.A. (1948). 
Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid 
  
 
 
 
 
 
 
83 
 
Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin). New England 
Journal of Medicine 238(23): 787-793. 
Fayemi, O.E. (2004). Crossreactivity of boar sperm monoclonal antibodies with 
human spermatozoa. African Journal of Biomedical Research 7: 37-39. 
Fujii, R., Morihara, F., Fukushima, K., Oku, T., Hifumi, E. and Uda, T. (2004). 
Recombinant antigen from Helicobacter pylori urease as vaccine against H. 
pylori-associated disease. Biotechnology and Bioengineering 86(7): 737-746. 
Galfre, G. and Milstein, C. (1981). Preparation of monoclonal antibodies: strategies 
and procedures. Methods in enzymology 73(Pt B): 3. 
Garner, D. L. (1984).  An Overview of Separation of X-and Y-Spermatozoa. In 
Proceedings of the Tenth Technical Conference on Artificial Insemination 
and Reproduction (National Association of Animal Breeders), pp. 87-92. 
Garner, D.L. and Seidel, G.E. (2008). History of commercializing sexed semen for 
cattle. Theriogenology 69(7): 886-895. 
Garner, D.L., Gledhill, B.L., Pinkel, D., Lake, S., Stephenson, D., Van Dilla, M.A. 
and Johnson, L.A. (1983). Quantification of the X- and Y-chromosome-
bearing spermatozoa of domestic animals by flow cytometry. Biology of 
Reproduction 28(2): 312-321. 
Gledhill, B. L. (1988). Selection and separation of X- and Y- chromosome-bearing 
mammalian sperm. Gamete Research 20(3): 377-395. 
Goldberg, E.H., Boyse, E.A., Bennett, D., Scheid, M. and Carswell, E.A. (1971). 
Serological demonstratation of H-Y (male) antigen on mouse sperm. Nature 
(Lond) 232: 478-480. 
Gordon, M.J. (1957). Control of sex ratio in rabbits by electrophoresis of spermatozoa.  
  
 
 
 
 
 
 
84 
 
Proceeding of the National Academy of Sciences of the United States of  
America 43(10): 913. 
Han, T.L., Flaherty, S., Ford, J. and Matthews, C. (1993). Detection of X-and Y-
bearing human spermatozoa after motile sperm isolation by swim-up. Fertility 
and Sterility 60(6): 1046. 
Handyside, A.H., Pattinson, J.K., Penketh, R.J.A., Delhanty, J.D.A., Winston, R.M.L. 
and Tuddenham, E.G.D. (1989). Biopsy of human preimplantation embryos 
and sexing by DNA amplification. Lancet 1: 347-349. 
Harlow, E. and Lane, D. (1988). Antibodies: A Laboratory Manual. Cold Spring 
Harbor Laboratory, Cold Spring Harbor, NY. 
Harvey, E.N. (1946). Can the sex of mammalian offspring be controlled. Journal of 
Heredity 37: 71-73. 
Hassan, D.A. (2005). Separation techniques for X and Y chromosome bearing human 
spermatozoa. Tshwane University of Technology. 
Hendriksen, P.J.M. (1999). Do X and Y spermatozoa differ in proteins?. 
Theriogenology 52(8): 1295-1307. 
Hendriksen, P.J.M., Tieman, M., Van Der Lende, T. and Johnson, L.A. (1993). 
Binding of anti‐H‐Y monoclonal antibodies to separated X and Y chromosome 
bearing porcine and bovine sperm. Molecular Reproduction and Development 
35(2): 189-196. 
Hifumi, E., Morihara, F., Hatiuchi, K., Okuda, T., Nishizono, A. and Uda, T. (2008). 
Catalytic features and eradication ability of antibody light-chain UA15-L 
against Helicobacter pylori. Journal of Biological Chemistry 283(2): 899-
907. 
  
 
 
 
 
 
 
85 
 
Hohenboken, W.D. (1999). Applications of sexed semen in cattle production. 
Theriogenology 52(8): 1421-1433. 
Hoppe, P.C. and Koo, G.C. (1984). Reacting mouse sperm with monoclonal H-Y 
antibodies does not influence sex ratio of eggs fertilized in vitro. Journal of  
Reproductive Immunology 6(1): 1-9. 
Hosoi, S., Nakamura, T., Higashi, S., Yamamuro, T., Toyama, S., Shinomiya, K. and 
Mikawa, H. (1982). Detection of human osteosarcoma-associated antigen (s) 
by monoclonal antibodies. Cancer Research 42(2): 654. 
Hossain, A.M., Barik, S. and Kulkarni, P.M. (2001). Lack of significant 
morphological differences between human X and Y spermatozoa and their 
precursor cells (spermatids) exposed to different prehybridization treatments. 
Journal of Andrology 22(1): 119. 
Howard, G.C. and Kaser, M.R. (2006). Making and using antibodies: A Practical 
Handbook. CRC Press, New York. 
Howes, E., Miller, N., Dolby, C., Hutchings, A., Butcher, G. and Jones, R. (1997). A 
search for sex-specific antigens on bovine spermatozoa using immunological 
and biochemical techniques to compare the protein profiles of X and Y 
chromosome-bearing sperm populations separated by fluorescence-activated 
cell sorting. Journal of Reproduction and Fertility 110(2): 195-204. 
Hudson, K., Ravelich, S. and Payne, L. (2012). Material and methods for sperm sex 
selection in pigs. WO patent WO/2012/002,823. 
Ishijima, S., Okuno, M. and Mohri, H. (1991). Zeta potential of human X‐and 
Y‐bearing sperm. International Journal of Andrology 14(5): 340-347. 
Iwata, H., Kimura, K., Hashimoto, S., Ohta, M., Tominaga, T. and Minami, N. (2002).  
  
 
 
 
 
 
 
86 
 
Role of G6PD activity on sex ratio and developmental competence of bovine 
embryos under oxidative stress. Journal of Reproduction and Development 
48:447-453. 
Iwata, H., Shiono, H., Kon, Y., Matsubara, K., Kimura, K., Kuwayama, T. and Monji, 
Y. (2008). Effects of modification of in vitro fertilization techniques on the sex 
ratio of the resultant bovine embryos. Animal Reproduction Science 
105:234-244. 
Jaffe, S., Jewelewicz, R., Wahl, E. and Khatamee, M. (1991). A controlled study for 
gender selection. Fertility and sterility 56(2): 254. 
Jamil, H., Samad, H., Qureshi, Z., Rehman, N. and Lodhi, L. (2007). Effect of bull 
and sperm preparation method on in vitro fertilization of buffalo oocytes. 
Pakistan Veterinary Journal 27(1): 29. 
Janeway, C.A. Jr., Travers, P. and Walport, M. (2001). Immunobiology: The Immune 
System in Health and Disease. 5th edition. Garland Science, New York. 
Jinming, H., Wei, Y., Naike, W. and Xiuwen, T. (2007). Use of the non-
electrophoretic method to detect testis specific protein gene for sexing in 
preimplantation bovine embryos. Asian Australasian Journal of Animal 
Sciences 20(6): 866. 
Johnson, L. A. (1992). Gender preselection in domestic animals using flow 
cytometrically sorted sperm. Journal Animal Science 70(suppl 2): 8-18. 
Johnson, L. and Welch, G. (1999). Sex preselection: high-speed flow cytometric 
sorting of X and Y sperm for maximum efficiency. Theriogenology 52(8): 
1323-1341. 
Johnson, L., Flook, J. and Look, M. (1987). Flow cytometry of X and Y chromosome‐  
  
 
 
 
 
 
 
87 
 
bearing sperm for DNA using an improved preparation method and staining 
with Hoechst 33342. Gamete Research 17(3): 203-212. 
Johnson, L.A. (1997). Advances in gender preselection in swine Journal of 
Reproduction and Fertility. Supplement 52: 255-266. 
Johnson, L.A. (2000). Sexing mammalian sperm for production of offspring: the state-
of-the-art. Animal Reproduction Science 60: 93-107. 
Johnson, L.A., Flook, J. and Hawk, H. (1989). Sex preselection in rabbits: live births 
from X and Y sperm separated by DNA and cell sorting. Biology of 
Reproduction 41(2): 199-203. 
Kageyama, S., Yoshida, I., Kawakura, K. and Chikuni, K. (2004). A novel repeated 
sequence located on the bovine Y chromosome: its application to rapid and 
precise embryo sexing by PCR. Journal of Veterinary Medical Science  
66:509-514. 
Kaneko, S., Oshio, S., Kobayashi, T., Izuka, R. and MOhri, H. (1984). Human X- and 
Y-bearing sperm differ in cell surface sialic acid content. Biochemical and 
Biophysical Research Communication 124: 950-955. 
Kitiyanant, Y., Saikhun, J., Siriaroonrat, B. and Pavasuthipaisit, K. (2000). Sex 
determination by polymerase chain reaction and karyotyping of bovine 
embryos at first cleavage in vitro. ScienceAsia 26: 9-13. 
Kobayashi, J., Oguro, H., Uchida, H., Kohsaka, T., Sasada, H. and Sato, E. (2004). 
Assessment of bovine X-and Y-bearing spermatozoa in fractions by 
discontinuous percoll gradients with rapid fluorescence in situ hybridization. 
Journal of Reproduction and Development 50(4): 463-469. 
Köhler, G. (1985). Derivation and diversification of monoclonal antibodies.  
  
 
 
 
 
 
 
88 
 
Bioscience Reports 5(7): 533-549. 
Köhler, G. and Milstein, C. (1975). Continuous cultures of fused cells secreting 
antibody of predefined specificity. Nature 256(5517): 495-497. 
Köhler, G. and Milstein, C. (1976). Derivation of specific antibody‐producing tissue 
culture and tumor lines by cell fusion. European journal of immunology 
6(7): 511-519. 
Köhler, G., Howe, S. and Milstein, C. (1976). Fusion between immunoglobulin‐	
secreting and nonsecreting myeloma cell lines. European journal of 
immunology 6(4): 292-295. 
Koo, G.C., Mittl, L.R. and Goldberg, C.L. (1979). Expression of H-Y antigen during 
spermatogenesis. Immunogenetics 9(1): 293-296. 
Koo, G.C., Stackpole, C.W., Boyse, E.A., Hämmerling, U. and Lardis, M.P. (1973). 
Topographical Location of H-Y Antigen on Mouse Spermatozoa by 
Immunoelectronmicroscopy. Proceedings of the National Academy of 
Sciences 70(5): 1502. 
Kordts, E. (1952). Investigations on the suitability of electrophoresis for the separation 
of male and female-determining sperm in the rabbit. (Trans. Title). Z. 
Tierzucht. Zuchtungsbiol 60: 221. 
Krikpatrick, B.W. and Monson, R.L. (1993). Sensitive sex determination assay 
applicable to bovine embryos derived from IVM and IVF. Journal of 
Reproduction & Fertility 98:335-340.   
Kudo, T., Sato, S. and Sutou, S. (1993). Sexing of bovine embryos with male-specific 
repetitive DNA by polymerase chain reaction: cloning and characterization of 
bovine male-specific repetitive DNA. Journal of  Reproduction and  
  
 
 
 
 
 
 
89 
 
Development 39:55-63. 
Laowtammathron, C., Lorthongpanich, C., Ketudat-Cairns, M., Hochi, S. and Parnpai, 
R. (2005). Factors affecting cryosurvival of nuclear-transferred bovine and 
swamp buffalo blastocysts: effects of hatching stage, linoleic acid-albumin in 
IVC medium and Ficoll supplementation to vitrification solution. 
Theriogenology 64(5): 1185-1196. 
 Leenaars, P.P.A.M., Hendriksen,C.F.M., De Leeuw, W.A.,Carat, F., Delahaut, P., Fischer, R., 
Halder, M., Hanley,W.C., Hartinger, J., Hau, J., Lindblad, E.B., Nicklas, W., 
Outschoorn, I.M. and Stewart-Tull, E. S. (1999). The production of polyclonal 
antibodies in laboratory animals. ATLA 27: 79-102. 
Leidenfrost, S., Boelhauve, M., Reichenbach, M., Güngör, T., Reichenbach, H.D., 
Sinowatz, F., Wolf, E. and Habermann, F.A. (2011). Cell Arrest and Cell 
Death in Mammalian Preimplantation Development: Lessons from the Bovine 
Model. PLoS One 6(7): e22121. 
Lemos, D.C., Rios, Á.F.L., Caetano, L.C., Lôbo, R.B., Vila, R.A., Martelli, L., 
Takeuchi, P.L. and Ramos, E.S. (2005). "Use of the TSPY gene for sexing 
cattle." Genetics and Molecular Biology 28(1): 117-119. 
Lin, C.H. and Hünig, T. (2003). Efficient expansion of regulatory T cells in vitro and 
in vivo with a CD28 superagonist. European Journal of Immunology 33(3): 
626-638. 
Littlefield, J.W. (1964). Selection of Hybrids from matings of fibroblasts in vitro and 
their presumed recombinants. Science 145: 709-710. 
Lobel, S. M., Pomponio, R. and Mutter, G. (1993). The sex ratio of normal and 
manipulated human sperm quantitated by the polymerase chain reaction.  
  
 
 
 
 
 
 
90 
 
Fertility and Sterility 59(2): 387-392. 
Machaty, Z., Paldi, A., Csaki, T., Varga, Z., Kiss, I., Bárándi, Z. and Vajta, G. (1993). 
Biopsy and sex determination by PCR of IVF bovine embryos. Journal of 
Reproduction & Fertility 98(2): 467-470. 
Machaty, Z., Paldi, A., Csaki, Z., Varga, Z., Kiss, I., Barandi, Z. and Vajta, G. (1993) 
Biopsy and sex determination by PCR of IVF bovine embryos. Journal of 
Reproduction and Fertility 98:467-470. 
Mallory, M., Chartrand, K. and Gauthier, E. (2007). GADD153 expression does not 
necessarily correlate with changes in culture behavior of hybridoma cells. 
BMC Biotechnology 7(1): 89. 
Manger, M., Bostedt, H., Schill, W.B. and Mileham, A. (1997). Effect of sperm 
motility on separation of bovine X- and Y-bearing spermatozoa by means of 
free-flow electrophoresis. Andrologia 29(1): 9-15. 
Mc Evoy (1992). Alternation of the sex ration. Animal Breeding Abstracts 60(2): 
97-111. 
Millán, J.L., Stigbrand, T., Ruoslahti, E. and Fishman, W.H. (1982). Characterization 
and use of an allotype-specific monoclonal antibody to placental alkaline 
phosphatase in the study of cancer-related phosphatase polymorphism. Cancer 
Research 42(6): 2444. 
Mohri, H., Oshio, S., Kaneko, S., Kobayashi, T. and Iizuka, R. (1986). Separation and 
Characterization of Mammalian X‐and Y‐bearing Sperm. Development, 
Growth & Differentiation 28: 35-3. 
Müller, U., Siebers, J.W., Zenzes, M.T. and Wolf, U. (1978). The testis as a secretory 
organ for H-Y antigen. Human Genetics 45(2): 209-213. 
  
 
 
 
 
 
 
91 
 
Mushayandebvu TI, Santoro NF, Lipetz KJ, Colon JM. 1995. Comparison of Percoll 
and swim-up techniques for sperm recovery in patients with male factor 
infertility. In IX World Congress on in vitro Fertilization and Alternative 
Assisted Reproduction (pp. 577-580). Monduzzi Editore, Bologna, Italy. 
Nevo, A., Michaeli, I. and Schindler, H. (1961). Electrophoretic properties of bull and 
of rabbit spermatozoa. Experimental cell research 23(1): 69-83. 
Ng, F.L.H. and Baker, H.W.G. (1992). Comparison of Percoll, mini-Percoll and swim-
up methods for sperm preparation from abnormal semen samples. Human 
Reproduction 7(2): 261-266. 
Ning, B., Tang, Y., Song, H., Yang, S. and Shen, H. (2012). Cloning and sequencing 
of the light chain variable region from NS-1 myeloma. Oncology Letter 3(5): 
1083-1086. 
Pace, M.M. (1990). Implications of sexed semen on the beef industry.  In Proceeding 
of the 39th Annual Florida Beef Cattle Short Course (pp. 238). Gainesville, 
Florida. 
Patthanawong, W., Pongpiachan, P. and Mekchay, S. (2010). Production of 
monoclonal antibody against male specific antigen on cell membrane of bovine 
spermatozoa. Indian Journal of Animal Research 44(1): 22-27. 
Pearson, P. and Bobrow, M. (1970). Fluorescent staining of the Y chromosome in 
meiotic stages of the human male. Journal of Reproduction and Fertility 
22(1): 177-179. 
Penfold, L., Holt, C., Holt, W., Welch, G., Cran, D. and Johnson, L. (1998). 
Comparative motility of X and Y chromosome-bearing bovine sperm separated 
on the basis of DNA content by flow sorting. Molecular Reproduction and  
  
 
 
 
 
 
 
92 
 
Development 50: 323-327. 
Penketh, R.J.A., Delhanty, J.D.A., Van Den Berghe, J.A., Finklestone, E.M., 
Handyside, A.H. and Malcolm, S. (1989). Rapid sexing of human embryos by 
non-radioactive in situ hybridization: potential for preimplantation diagnosis of 
X-linked disorders. Prenatal Diagnosis 9: 489-500. 
Peter, A.T., Jones, P.P. and Robinson, J.P. (1993). Fractionation of bovine 
spermatozoa for sex selection: A rapid immunomagnetic technique to remove 
spermatozoa that contain the H-Y antigen. Theriogenology 40(6): 1177-1185. 
Pilz, A. (1952). The behavior of mammalian spermatozoa in the electric field. (Trans. 
Title). Z. Tierzucht. Zuchtungsbiol 60: 315. 
Pinkel, D., Lake, S., Gledhill, B.L. van Dilla, M.A., Stephenson, D and Watchmaker, 
G. (1982). High resolution DNA content measurement of mammalian sperm. 
Cytometry 3: 1-9. 
Plucienniczak, A., Skowronski, J. and Jaworski, J. (1982). Nucleotide sequence of 
bovine 1.715 satellite DNA and its relation to other bovine satellite sequences. 
Journal of Molecular Biology 158: 293-304.  
Poudrier, J. and Owens, T. (1995). Th1 and Th2 help for B cells: differential capacity 
for induction of autonomous responsiveness to IL-2. International 
immunology 7(6): 1021-1027. 
Prasad, S., Ch.*, Rangasamy, S. and Satheshkumar, S. (2010). Sex Preselection in 
Domestic Animals - Current status and Future prospects. Veterinary World 
3(7): 346-348. 
Quinlivan, W., Preciado, K., Long, T.L. and Sullivan, H. (1982). Separation of human 
X and Y spermatozoa by albumin gradients and Sephadex chromatography.  
  
 
 
 
 
 
 
93 
 
Fertility and Sterility 37(1): 104. 
Rath, D., Long, C., Dobrinsky, J., Welch, G., Schreier, L. and Johnson, L. (1999). In 
vitro production of sexed embryos for gender preselection: high-speed sorting 
of X-chromosome-bearing sperm to produce pigs after embryo transfer. 
Journal Animal Science 77(12): 3346-3352. 
Rattanasuk, S., Parnpai, R. and Ketudat-Cairns, M. (2011). Multiplex polymerase 
chain reaction used for bovine embryo sex determination. Journal of 
Reproduction and Development 57(4): 539-542. 
Reed, K.C., Matthaei, K.I., Mann, D.A., Beaton, S. and Matthews, M.A. (1989) 
Determination of genetic sex in ruminants using Y-chromosome specific 
polynucleotides. Patent Cooperation Treaty No. WO 1989;89/07154. 
Renaville, R., Haezebroeck, V., Parmentier, I., Pirard, M., Fontaine, S. and Portetelle, 
D. (2002). Sex preselection in mammals. Biotechnology in animal 
husbandry 5: 225-233. 
Resende, M.V., Lucio, A.C., Perini, A.P., Oliveira, L.Z., Almeida, A.O., Alves, 
B.C.A., Moreira-Filho, C.A., Santos, I.W. and Hossepian de Lima, V.F.M. 
(2011). Comparative validation using quantitative real-time PCR (qPCR) and 
conventional PCR of bovine semen centrifuged in continuous density gradient. 
Arquivo Brasileiro de Medicina Veterinária e Zootecnia 63: 544-551. 
Rivière-Dobigny, T., Doan, L.P., Quang, N.L., Maillard, J.C. and Michaux, J. (2009). 
Species identification, molecular sexing and genotyping using non-invasive 
approaches in two wild bovids species: Bos gaurus and Bos javanicus. Zoo 
Biology 28:127-136. 
Rizvi, S.A. and Bashir, K. (2004). Other therapy options and future strategies for  
  
 
 
 
 
 
 
94 
 
treating patients with multiple sclerosis. Neurology 63: 47-54. 
Roberts, A.M. (1972). Gravitational Separation of X and Y Spermatozoa. Nature 
238(5361): 223-225. 
Rohde, W., Porstmann, T. and Dorner, G. (1973). Migration of Y-bearing human 
spermatozoa in cervical mucus. Journal of Reproduction and Fertility 33: 
167-169. 
Rohde, W., Porstmann, T., Prehn, S. and Dörner, G. (1975). Gravitational pattern of 
the Y-bearing human spermatozoa in density gradient centrifugation. Journal 
of Reproduction and Fertility 42(3): 587-591. 
Roitt, I., Brostoff, J. and Male, D. (2001). Immunology. Sixth Edition, New York: 
Mosby. 
Ross, A., Robinson, J.A. and Evans, H. (1975). Failure to confirm separation of X-and 
Y-bearing human sperm using BSA gradients. Nature 253: 354-355. 
Rothschild (1960). The heat production of human spermatozoa and seminal plasma; 
with comparative observations on bull semen. Proceedings of the Royal 
Society of London. Series B, Biological Sciences 152(948): 298-310.  
Russell, W., Patel, G., Precious, B., Sharp, I. and Gardner, P. (1981). Monoclonal 
antibodies against adenovirus type 5: preparation and preliminary 
characterization. Journal of General Virology 56(Pt 2): 393. 
Samura, O., Miharu, N., He, H., Okamoto, E. and Ohama, K. (1997). Assessment of 
sex chromosome ratio and aneuploidy rate in motile spermatozoa selected by 
three different methods. Human Reproduction 12(11): 2437-2442. 
Sarkar, S. (1984). Motility, expression of surface antigen, and X and Y human sperm 
separation in in vitro fertilization medium. Fertility and Sterility 42:899-905. 
  
 
 
 
 
 
 
95 
 
Sarkar,S., Jolly, D.J., Friedmann, T. and Jones, O. (1984). Swimming behavior of X 
and Y human sperm. Differentiation 27: 120-125. 
Schilling, E., Lafrenz, R. and Klobasa, F. (1978). Failure to Separate Human x‐and 
y‐Chromosome Bearing Spermatozoa by Sephadex Gel‐Filtration. Andrologia 
10(3): 215-217. 
Schroder, A., Miller, J.R., Thomsen, P.D. and Avery, B. (1990) Sex determination of 
bovine embryos using the polymerase chain reaction. Animal Biotechnology 
1:121-133. 
Schroder, V. (1941). Artificial sex regulation of the off- spring of mammals and its 
biological control. (Trans, title). Z. Tierzucht. Zuchtungsbiol. 50:1. 
Scott Sills, E., Kirman, I., Thatcher III, S. and Palermo, G.D. (1998). Sex-selection of 
human spermatozoa: evolution of current techniques and applications. 
Archives of Gynecology and Obstetrics 261(3): 109-115. 
Sharma, R. K., Seifarth, K. and Agarwal, A. (1997). Comparison of single-and two-
layer Percoll separation for selection of motile spermatozoa. International 
journal of fertility and menopausal studies 42(6): 412-417. 
Shettles, L. (1961). Human spermatozoa shape in relation to sex ratios. Fertility and 
Sterility 12: 502-508. 
Shiels, B.R., McDougall, C., Tait, A. and Brown, C.G.D. (1986). Identification of 
infection-associated antigens in Theileria annulata transformed cells. Parasite 
Immunology 8(1): 69-77. 
Shone, C., Wilton-Smith, P., Appleton, N., Hambleton, P., Modi, N., Gatley, S. and 
Melling, J. (1985). Monoclonal antibody-based immunoassay for type A 
Clostridium botulinum toxin is comparable to the mouse bioassay. Applied  
  
 
 
 
 
 
 
96 
 
and Environmental Microbiology 50(1): 63-67. 
Shulman, M., Wilde, C. and Köhler, G. (1978). A better cell line for making 
hybridomas secreting specific antibodies. Nature 276: 269-270. 
Siljander, A.A. (1936). Regulation of the sex of domesticated animal by meals of 
electophoretically separated sperm. (Trans. Tille). Sbornik Trudov Zootek. 
Kaf. S.h. Skol. Kirov: 148. 
Sills, E.S., Kirman, I., Colombero, L.T., Hariprahad, J., Rosenwaks, Z. and Palermo, 
G. (1998). H-Y antigen expression patterns in human X- and Y-chromosome-
bearing spermatozoa. American Journal of Reproductive Immunology 40: 
43-47. 
Simson, J.L. and Larson, S.A. (2002). Sex selection. Assisted reproduction 
technology. Cambridge University. United Kingdom 387-389. 
Slovin, S., Frisman, D., Tsoukas, C., Royston, I., Baird, S., Wormsley, S., Carson, D. 
and Vaughan, J. (1982). Membrane antigen on Epstein--Barr virus-infected 
human B cells recognized by a monoclonal antibody. Proceedings of the 
National Academy of Sciences 79(8): 2649. 
Smith, S., Hosid, S. and Scott, L. (1995). Use of postseparation sperm parameters to 
determine the method of choice for sperm preparation for assisted reproductive 
technology. Fertility and Sterility 63(3): 591-597. 
Spaulding, G.F. (1997). Methods for determining antibodies specific for sex 
associated sperm membrane proteins. United States Patents 5,660,997. 
Sripunya, N., Somfai, T., Inaba, Y., Nagai, T., Imai, K. And Parnpai, R. (2009). A 
comparison of cryotop and solid surface vitrification methods for the 
cryopreservation of in vitro matured bovine oocytes. Journal of  
  
 
 
 
 
 
 
97 
 
Reproduction and Development 56(1): 176-181. 
Steeno, O., Adimoelja, A. and Steeno, J. (1975). Separation of X- and Y-bearing 
human spermatozoa with the sephadex gel-filtration method. Andrologia 7(2): 
95-97. 
Stern, P.L., Willison, K.R., Lennox, E., Galfrè, G., Milstein, C., Sécher, D., Ziegler, 
A. and Springer, T. (1978). Monoclonal antibodies as probes for differentiation 
and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem 
cells. Cell 14(4): 775-783. 
Sugaya, S., Ohashi, H. and Shinozawa, T. (1997). Expression and purification of a 
recombinant human glycoprotein in mouse hybridoma SP2/0-AG14 cells. 
Biotechnology letters 19(2): 185-188. 
Summer, A.T. and Robinson, J.A. (1976). A difference in dry mass between the heads 
of X- and Y-bearing human spermatozoa. Journal of Reproduction and 
Fertility 48: 915. 
Sundström, B., Nathrath, W. and Stigbrand, T.I. (1989). Diversity in immunoreactivity 
of tumor-derived cytokeratin monoclonal antibodies. Journal of 
Histochemistry & Cytochemistry 37(12): 1845. 
Taggart, R.T. and Samloff, I.M. (1983). Stable antibody-producing murine 
hybridomas. Science 219(4589): 1228. 
Treanor, J., Dolin, R. and Madore, H.P. (1988). Production of a monoclonal antibody 
against the Snow Mountain agent of gastroenteritis by in vitro immunization of 
murine spleen cells. Proceedings of the National Academy of Sciences 
85(10): 3613. 
Van Dilla, M. (1985). Overview of flow cytometry: instrumentation and data analysis.  
  
 
 
 
 
 
 
98 
 
Flow Cytometry: Instrumentation and Data Analysis, Van Dilla et al.  
(Eds.): 1-8. 
Van Vliet, R.A., Verrinder Gibbins, A.M. and Walton, J.S. (1989). Livestock embryo 
sexing: A review of current methods with emphasis on Y-specific DNA 
probes. Theriogenology 32:421-438. 
Vesselinovitch, S. (1960). Electrophoresis of spermatozoa and sex control. The 
Cornell veterinarian 50: 326. 
Vidal, F., Moragas, M., Català, V., Torelló, M., Santaló, J., Calderón, G., Gimenez, 
C., Barri, P., Egozcue, J. and Veiga, A. (1993). Sephadex filtration and human 
serum albumin gradients do not select spermatozoa by sex chromosome: a 
fluorescent in-situ hybridization study. Human reproduction (Oxford, 
England) 8(10): 1740. 
Wachtel, S., Nakamura, D., Wachtel, G., Felton, W., Kent, M. and Jaswaney, V. 
(1988). Sex selection with monoclonal HY antibody. Fertility and Sterility 
50(2): 355-360. 
Watkins, A., Chan, P., Patton, W., Jacobson, J. and King, A. (1996). Sperm kinetics 
and morphology before and after fractionation on discontinuous Percoll 
gradient for sex preselection: computerized analyses. . Systems Biology in 
Reproduction Medicine 37(1): 1-5. 
Windsor, D.P., Evans, G. and White, I.G. (1993). Sex predetermination by separation 
of  X and Y chromosome-bearing sperm. Reproduction Fertility and 
Development 5: 155-171. 
Wong, C.C., Loewke, K.E., Bossert, N.L., Behr, B., De Jonge, C.J., Baer, T.M. and 
Pera, R.A.R. (2010). Non-invasive imaging of human embryos before 
  
 
 
 
 
 
 
99 
 
embryonic genome activation predicts development to the blastocyst stage. 
Nature biotechnology 28(10): 1115-1121. 
Woof, J.M. and Kerr, M.A. (2006). The function of immunoglobulin A in immunity. 
The Journal of Pathology 208(2): 270-282. 
Zavos, P. M. (1983). Preconception sex determination via intra-vaginal administration 
of HY antisera in rabbits. Theriogenology 20(2): 235-240. 
Zavos, P. M. (1985). Sperm separation attempts via the use of albumin gradients in 
rabbits. Theriogenology 23(6): 875-879. 
 
 
 
  
 
 
 
 
 
 
100 
 
 
 
 
 
 
 
 
 
 
APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
101 
 
APPENDIX I 
MEDIA AND REAGENTS 
 
1. 100x L-glutamine (Sigma®) 
-L-glutamine    2.92    g 
-Water for injection   100   ml 
Filter sterilization (0.2 µm) 
Aliquot 10 ml/tube and store at -20oC 
 
2. 1000x Penicillin + Streptomycin 
-Penicillin G sodium   5 × 106   unit/vial 
-Streptomycin    5   g/vial 
-Water for injection    50   ml 
Filter sterilization (0.2 µm) 
Aliquot 1 ml/tube and store at -20oC 
 
3. RPMI-1640 (Gibco®) size 1 bag/1 L 
-RPMI     1   bag 
-NaHCO3    2   g 
-Water for injection   1   L 
-10 N HCl 
Dissolve RPMI-1640 powder and 2 g NaHCO3 in 900 µl of water for injection
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using magnetic stirrer. Adjust the pH to 7.0 by adding 10 N HCl and add water 
for injection to final volume 1 L.  Filter sterilization (0.2 µm) and store at 4oC. 
Check for contamination by aliquot 2 ml into cell culture disk and store at 
37oC in a humidified atmosphere of 5% CO2 in air overnight.   
 
4. Fetal bovine serum (HyClone FetalClone I, U.S. Origin) 
-Heat inactivation at 56 oC for 30 min 
-Aliquot 100 ml/tube and store at 4oC 
 
5. Complete RPMI-1640 (cRPMI) 
-RPMI     400   ml 
-100x L-glutamine   5   ml 
-1000x penicillin + streptomycin 0.5   ml 
-fetal bovine serum   100   ml 
Mix all reagents and store at 4oC 
 
6. Polyethylene glycol (PEG-4000) 
-warm the autoclaved PEG-4000 at 65oC until completely melt. Add 15% 
DMSO in PBS with ratio 5 g PEG-4000/25ml 15% DMSO in PBS. Store at 
4oC. 
 
7. 100x Aminopterin (A) stock (Sigma®) 
-Aminopterin    1.76   g 
-Water for injection   100   ml 
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-1 N NaOH 
Dissolve 1.76 g aminopterin in 90 ml water of injection by add small volume 
of 1 N NaOH. Adjust the pH using HCl to 7.2 and add water of injection to 
final volume of 100 ml. Filter sterilization and aliquot 10 ml/tube covered with 
aluminum foil and store at -20oC. 
 
8. 100x Hypoxanthine and thymidine (HT) stock (Sigma®) 
-Hypoxanthine    136.1   mg 
-Thymidine    38.75   mg 
-Water for injection   100   ml 
-1 N NaOH 
Dissolve hypoxanthine and thymidine in 90 ml water of injection by add small 
volume of 1 N NaOH. Adjust the pH using NaOH to 8.1-8.5 and add water of 
injection to final volume 100 ml. Filter sterilization and aliquot 10 ml/tube. 
Store at -20oC.  
 
9. HAT working media 
-cRPMI    100   ml 
-100x HT stock   1   ml 
-100x A stock    1   ml 
Mix all reagents and store at 4oC. Prepare freshly before each use. 
 
10. HT working media 
-cRPMI    100   ml 
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-100x HT stock   1   ml 
Mix all reagents and store at 4oC. Prepare freshly before each use. 
 
11. Phosphate buffer saline (PBS), pH 7.2 
-NaCl     8.50   g 
-Na2HPO4    1.07   g 
-NaH2PO4    0.30   g 
-Deionized H2O to   1000   ml 
Dissolve all reagents and fill deionized water up to 1000 ml. Adjust pH to 7.2. 
Filter sterilization with 0.2 µm and store at room temperature. 
 
12. Freezing media 
-cRPMI    90   ml 
-DMSO    10   ml 
Mix all reagents and store at 4oC. (Not allow to filter sterilization) 
 
13. Phosphate buffer saline + 0.05% Tween20 (PBST), pH 7.2 
-PBS     100   ml                          
-0.05% Tween20   50   µl                         
Mix all reagents and store at room temperature 
14. Acrylamide solution (30.8%T 2.7%Cbis) 
-Acrylamide    60   g 
-bisacrylamide   1.6   g 
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-Distilled water to    200   µl 
Store up to 3 months at 4oC in the dark  
 
15. 10% Sodium dodecyl sulfate (SDS) 
- Sodium dodecyl sulfate  10   g 
- Distilled water to    100   ml 
Store up to 6 months at room temperature 
 
16. 10% Ammonium persulfate 
-Ammonium persulfate  0.1   g 
-Distilled water to    1   ml 
Prepare just prior to use, do not store 
 
17. 4x Resolving gel buffer 
-Tris     36.3   g 
-Distilled water   40   ml 
-HCl to pH 8.8 
-Distilled water to    200   ml 
Store up to 3 months at 4oC 
 
18. 4x Stacking gel buffer 
-Tris     3   g 
-Distilled water   40   ml 
-HCl to pH 6.8 
  
 
 
 
 
 
 
106 
 
-Distilled water to    50   ml 
Store up to 3 months at 4oC 
 
19. 2x Loading dye 
-4x stacking gel buffer  2.5   ml 
-10% SDS    4   ml 
-Glycerol     2   ml 
-Bromophenol Blue   2   mg 
-2-Mercaptoethanol   100   µl 
-Distilled water to    10   ml 
Store in 0.5 ml aliquots at -20oC up to 6 months 
 
20. Tank buffer 
-Tris      30.28   g 
-Glycine    144.13   g 
-SDS     10   g 
-Distilled water to    10   L 
 
21. Mixture of separating gel and stacking gel 
12% separating gel   4% stacking gel 
-12%Acrylamide solution  3.2    0.83 ml 
-Distilled water   2.64    2.77 ml 
-4x Separating gel buffer (pH 8.8) 2    - ml 
-4x Stacking gel buffer (pH6.8) 1.26    - ml 
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-10% SDS    80    50 µl 
-10% Ammonium persulfate  80    50 µl 
-TEMED    8    5 µl 
 
22. Coomassie Blue staining solution 
-Coomassie Brilliant Blue R250 0.5   g 
-Methanol    800   ml 
Stir until dissolved, then add 
-Acetic acid     140   ml 
-Distilled water to    2   L 
Store at room temperature for up to 6 months 
 
23. Destain solution 
-Methanol    400   ml 
-Acetic acid    70   ml 
-Distilled water to    1   L 
Store at room temperature 
 
24. Transfer buffer (Western blot) 
-Tank buffer    450   ml 
-Methanol    50   m 
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PUBLICATION  
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